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The global burden of methicillin resistant Staphylococcus aureus (MRSA) can be largely 
attributed to S. aureus’ ability to acquire the resistance element, SCCmec (Staphylococcal 
chromosome complex mec). Classification of SCCmec types is an essential component of 
staphylococcal epidemiology and is based on the arrangement and classes of the mec and ccr 
gene complexes and Open Reading Frames (ORFs) in the joining (J) regions. At least twelve 
SCCmec types and numerous subtypes have been described to date. We identified potentially 
novel and novel variant SCCmec types in MRSA isolates from a tertiary hospital in Cape Town, 
South Africa. This study aimed to describe the molecular structure and possible origin of these 
novel elements in our setting, and to determine the prevalence of these SCCmec types. 
Methods 
We screened 87 clinical MRSA and 100 methicillin resistant coagulase negative Staphylococci 
(MR-CoNS) isolates using a multiplex PCR for SCCmec typing. Additional typing employed a 
combination of six multiplex PCRs on 3 MRSA isolates each from the novel and novel variant 
types. Whole genome sequencing (WGS) was performed on representative isolates using the 
Illumina next-generation sequencing platform. 
Results 
Among the MRSA isolates, 36% contained the novel SCCmec type (ccrC/Class A mec), 
followed by SCCmec IV (24%), the novel variant SCCmec type (ccrA1B1, ccrC/Class B mec) 
(17%) and SCCmec III (11%). Only one MR-CoNS isolate contained the novel type. Preliminary 
genomic analysis support the PCR findings, and show the presence of a possible truncated 
SCCHg element in the novel, novel variant and SCCmec III isolates. 
Discussion 
We have successfully optimized and implemented two SCCmec typing assays on MRSA and 
MR-CoNS isolates in our setting and in doing so, identified possible novel and novel variant 
SCCmec elements. The novel SCCmec type is common among local MRSA isolates, and may 
reflect clonal spread within the hospital. Preliminary WGS analysis showed that these isolates 
are composites of SCCHg and SCCmec elements, however further phylogenetic analysis is 
required to provide insights into how these elements emerged. 





Die wêreldwye las van metisillienweerstandige Staphylococcus aureus (MRSA) kan toegeskryf 
word aan S. aureus se vermoë om die antibiotiese weerstandbiedende element, 
“Staphylococcal chromosome complex mec” (SCCmec) op te neem. Klassifikasie van SCCmec 
is ‘n essensiële komponent in die epidemiologiese ondersoek van stafilokokkus-infeksies en is 
gebaseer op die kombinasies van verskillende “mec” en “ccr” geenkomplekse en oopleesrame 
(OLR) in die “joining (J) regions” van die element. Ten minste twaalf SCCmec-tipes en verskeie 
subtipes is al beskryf en gepubliseer en kom in beide MRSA en metisillienweerstandige 
koagulase negatiewe stafilokokke (MR-KoNS) voor. Ons het ‘n potensiële nuwe SCCmec-tipe 
en variant tipe in MRSA-isolate van Tygerberg Akademiese Hospitaal ontdek. In hierdie studie 
het ons gepoog om die molekulêre struktuur, moontlike oorsprong en voorkoms van die nuwe 
tipe SCCmec-isolate in hierdie instelling te ondersoek. 
Metodes 
‘n veelvoudige polimerasekettingreaksie (vPKR) is op 87 MRSA en 100 MR-KoNS-isolate 
uitgevoer. Verdere epidemiologiese ondersoek is vir drie isolate elk van die nuwe tipe en nuwe 
variant tipe gedoen met ‘n protokol wat die gebruik van ses mPKR-reaksies insluit. Heel-
genoomvolgordebepaling is op verteenwoordigende isolate met Illumina tegnologie gedoen. 
Resultate 
Ses-en-dertig persent van die MRSA isolate het die nuwe SCCmec tipe (ccrC/Klas A mec) 
bevat, gevolg deur SCCmec IV (24%), die nuwe variant (ccrA1B1, ccrC/Class B mec) (17%) en 
SCCmec III (11%). Slegs een MR-KoNS-isolaat het die nuwe tipe bevat. Voorlopige analise van 
die genome van hierdie nuwe tipes ondersteun die PKR resultate, en dui op die voorkoms van 
‘n verkorte SCCHg element in die nuwe, variant en SCCmec III-isolate. 
Bespreking 
Ons het twee SCCmec-tiperingsmetodes in ons instelling suksesvol geöptimiseer en 
geïmplementeer op MRSA- en MR-KoNS-isolate en daardeur ‘n nuwe SCCmec-tipe en nuwe 
variant SCCmec-tipe ontdek. Die nuwe SCCmec tipe is algemeen in die plaaslike MRSA-isolate 
en dit mag ‘n aanduiding wees dat hierdie tipe op ‘n klonale wyse versprei in die hospitaal. Heel-
genoomvolgordebepalings-analise wys daarop dat hierdie nuwe elemente samestellings van 
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SCCHg en SCCmec elemente is, maar verdere filogenetiese ondersoeke moet uitgevoer word, 
om insig te gee oor die oorsprong en verspreiding van hierdie nuwe element. 
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Chapter 1: Literature Review 
1.1 Introduction 
Staphylococcus aureus (S. aureus) is a commensal microorganism that forms part of naturally 
occurring flora in the anterior nares of approximately 30% of the human population and yet, it is 
one of the leading causes of bacterial infection worldwide (DeLeo et al. 2010). Unlike most other 
members of its genus, S. aureus is coagulase positive, giving it the ability to cause blood 
clotting by converting fibrinogen to fibrin. Fibrin clots protect against phagocytosis and other 
host defenses and consequently contributes to its virulence (McAdow et al. 2012). 
Staphylococcus aureus is the most pathogenic member of its genus (Shore & Coleman 2013), 
with infections that range from minor skin ailments to serious and often fatal systemic infections 
such as skin and soft tissue infections (SSTI)  and necrotizing pneumonia (DeLeo et al. 2010). 
Staphylococcal infections occur in patients from all demographic descriptions, with disease 
outcomes dependent on the interplay between bacterial virulence and the host’s immune 
response (Shore & Coleman 2013). Furthermore, S. aureus has the ability to rapidly acquire 
resistance, in particular to the β-lactam class of antibiotics; this class includes penicillin as well 
as methicillin and the cephalosporins.  
1.2 Methicillin resistant Staphylococcus aureus (MRSA) 
1.2.1 Overview 
Staphylococcus aureus can be divided into two clinically significant groups, methicillin sensitive 
S. aureus (MSSA) and methicillin resistant S. aureus (MRSA). Methicillin is a member of the β-
lactam family of antibiotics, which have a high affinity for penicillin-binding-proteins (PBPs) in 
the cell wall. When PBPs are bound by the β-lactams, peptidoglycan synthesis is interrupted, 
leading to cell death. MSSA isolates may develop resistance to β-lactams by the acquisition of a 
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specific large mobile genetic element (MGE), known as the staphylococcal cassette 
chromosome mec (SCCmec) (Katayama et al. 2000). SCCmec carries the mecA gene, which 
encodes an altered PBP known as PBP2a or PBP2’. The PBP2a is a 78-kDa class B 
transpeptidase that catalyses the formation of cross-bridges in bacterial cell wall peptidoglycan. 
It has a very low binding affinity for β-lactam antibiotics (Hanssen & Ericson Sollid 2006) and as 
a result peptidoglycan synthesis will continue even in the presence of β-lactams and the cell will 
survive. 
1.2.2 History of MRSA 
Within two years of the introduction of penicillin in 1941, resistance was reported in S. aureus. 
Shortly after, the first description of penicillinase (penicillin hydrolyzing enzymes) producing S. 
aureus strains was made (Chambers 2001). In 1959, the first penicillinase stable penicillin, 
methicillin, was discovered (Jevons 1961). Methicillin-resistant S. aureus was first identified, one 
year after the introduction of the semisynthetic penicillin, methicillin, in patients who were 
recently admitted to a healthcare facility or who underwent surgery. These infections were 
termed healthcare associated MRSA (HA-MRSA) (Chongtrakool et al. 2006; DeLeo et al. 2010). 
However, in the 1990s MRSA was observed in patients who had none of the typical risk factors 
such as recent hospital admission, residence in a nursing home or other conditions which may 
have caused exposure to healthcare facilities or MRSA infected persons (Huang et al. 2006). 
These patients displayed SSTIs as well as necrotizing pneumonia and this was termed 
community associated MRSA (CA-MRSA) (Barbier et al. 2010). Initially, patients with CA-MRSA 
infections had case similarities and many cases were identified based on specific molecular 
characteristics, such as clonal type and the resistance elements they carried. In recent years it 
has become difficult to distinguish between CA- and HA-MRSA, especially with the significant 
rise in CA-MRSA cases (DeLeo et al. 2010; Falagas et al. 2013). 
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1.2.3 Transmission of MRSA 
The increased incidence of CA-MRSA can be attributed to immunosuppression, community and 
environmental exposures; and high risk sexual behaviour such as having more than two sexual 
partners or having anonymous sex partners (Cole & Popovich 2013). The Centers for Disease 
Control and Prevention (CDC) include the following environmental factors as risks for MRSA 
transmission ( http://www.cdc.gov/niosh): 
 Crowding 
 Frequent skin-to-skin contact 
 Compromised skin integrity 
 Contaminated items and surfaces 
 Lack of cleanliness 
In addition to these factors, it has been shown that patients with a high MRSA nasal burden 
(colonization) are more likely to develop infection (Datta & Huang 2008). 
1.2.4 Diagnosis of MRSA infection 
MRSA is diagnosed through standard laboratory procedures, which include phenotypic 
speciation and antibiotic resistance tests on either cultured clinical isolates, or performed 
directly on tissues, nasal swabs, blood cultures and other clinical specimens. Identification and 
susceptibility testing on isolates can be accomplished by a variety of manual and automated 
tests, including the VITEK®2 automated microbial identification and antibiotic susceptibility 
testing system (bioMérieux), API ID strip system (bioMérieux), disk diffusion tests (MAST 
Diagnostics) and E-tests (bioMérieux). Molecular tests like 16S rRNA polymerase chain reaction 
(PCR), the GeneOhm™ MRSA assay (BD) and the GeneXpert® MRSA assay (Cepheid) are 
available, but are less common, especially in resource-limited settings (Marlowe & Bankowski 
2011). Molecular assays can be performed both on cultured isolates as well as certain clinical 
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samples. The potential advantage in performing them directly on clinical specimens is that this 
may allow for more timely initiation of appropriate antibiotic therapy and/or institution of infection 
control protocols. However, the evidence for the clinical or economic benefit of these rapid tests 
is still conflicting (Yang & Rothman 2004; Brown et al. 2005). 
1.2.5 Treatment of MRSA infection 
MRSA cannot be treated by conventional first-line therapy, such as oxacillin or similar 
penicillinase stable β-lactam antibiotics. Minor MRSA infections, such as boils or lesions, can be 
treated by incision and drainage of the affected area and decolonization of MRSA on the skin 
with antiseptic substances. In patients with systemic illness, trimethoprim-sulfamethoxazole, 
doxycycline, clindamycin, daptomycin, vancomycin and linezolid may be effective (Liu et al. 
2011). While uncommon, there has been an increase in the reporting of Vancomycin 
intermediate S. aureus (VISA) and Vancomycin resistant S. aureus (VRSA) strains. This is a 
serious concern, since other last resort treatment options are limited and efficacy varies greatly 
depending on the clinical setting (Rivera & Boucher 2011). 
1.2.6 Epidemiology 
Both HA- and CA-MRSA pose a significant burden of high morbidity, mortality and cost of 
healthcare. Worldwide data shows that the highest rates (upwards of 50%) of MRSA are found 
in North America, South America and Asia. In contrast, most Scandinavian countries as well as 
the Netherlands have extremely low prevalence rates (Stefani et al. 2012). This is attributed to 
the search-and-destroy policies that have been implemented in the Netherlands and many 
Scandinavian countries. These policies vary in strictness, but aim to isolate and eradicate 
MRSA infections as soon as they are identified (Dekker & Broek 2010; Johnson 2011). The 
rates in Australia, China and Southern European countries range from 25 to 50% (Stefani et al. 
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2012). This is similar to data from most African countries that show that the prevalence of 
MRSA is lower than 50% (Falagas et al. 2013). 
The first South African outbreak was recorded in 1986-1987 in Johannesburg (Falagas et al. 
2013). Despite the implementation of improved infection control practices and the apparent 
decline of MRSA reported from 2006 to 2011, MRSA remains a concern (Falagas et al. 2013). 
At Tygerberg Hospital in 2008, 29% of all clinical specimens submitted to the laboratory were 
MRSA (Oosthuysen 2013). One study indicated a prevalence of 23% in Gauteng and 27% in 
KwaZulu-Natal (Moodley et al. 2010). A more recent study indicated that MRSA occurs in 29% 
to 46% of clinical S. aureus isolates in South Africa (Jansen van Rensburg et al. 2011). 
To better understand the development of resistance and spread of MRSA in hospitals, it is 
important to study them on the genetic level. These studies allow researchers to distinguish 
between the spread of resistant isolates (clonal transmission) versus the spread of resistance 
genes (horizontal transmission) (Hanssen & Ericson Sollid 2006). It is vital to know the 
mechanism of the spread of MRSA within each community in order to properly monitor and 
control the progression of resistance. 
Another concern is the increasing incidence of resistant strains amongst livestock, leading to 
livestock-associated MRSA (LA-MRSA). Livestock-associated MRSA infections are harder to 
treat and have been strongly associated with strains adept at immune evasion and carrying 
antibiotic resistance and other virulence factors. Infected meat also opens up another pathway 
for transmission of resistant strains into human hosts (Lindsay 2014). 
1.3 SCCmec 
1.3.1 Origin of the SCCmec element 
Most resistance elements have a broad host range, however the large mobile genetic element, 
SCCmec, has so far only been found in staphylococci (Hiramatsu et al. 2001). This gene 
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cassette is not inherent to S. aureus and the source was unknown (Pinho et al. 2001) until 
recently. Research now suggests that the SCC and mecA existed separately until mecA entered 
S. aureus through horizontal gene transfer between staphylococci and other Gram-positives 
shortly after the introduction of methicillin (Hanssen & Ericson Sollid 2006; Shore & Coleman 
2013). It has been shown that SCCmec possibly originated from the acquisition of the mecA 
gene carried by Staphylococcus fleuretti (Tsubakishita et al. 2010). Another study suggested 
that mecA originating from Staphylococcus sciuri is a possible precursor for the mec genes 
found in most SCCmec elements today (Bouchami et al. 2011). Although it is generally 
accepted that MRSA developed from genes first found in coagulase negative staphylococci 
(CoNS), debate exists whether the reservoir for SCCmec elements is mainly CoNS or if it is 
MRSA itself. Researchers have found contradicting results and the topic warrants further 
investigation (Hanssen & Ericson Sollid 2006). The two contradicting theories of the origin of 
MRSA and SCCmec are explained by Deurenberg et al. (2007). The first is the single clone 
theory, which suggests that all MRSA clones have one common ancestor and that the 
dissemination of a couple of resilient clones drives the global spread of MRSA. The basis of this 
theory is that SCCmec was introduced into S. aureus only once. The second theory is widely 
accepted and suggests that MRSA evolved multiple times by independent lateral gene transfer 
events (Deurenberg et al. 2007; Stojanov et al. 2013). This is supported by the distribution of 
similar SCCmec elements in unrelated MRSA strains and different SCCmec elements in similar 
strains (Musser & Kapur 1992; Deurenberg et al. 2007; Stojanov et al. 2013). 
1.3.2 Overall structure of SCCmec 
The SCCmec element is a chromosomal mobile antibiotic resistance island. It is integrated in a 
site- and orientation specific manner near the S. aureus origin of replication, at the unique 15 bp 
bacterial chromosomal attachment site (attBSCC) in orfX. The function of orfX was unknown 
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until recently, when it was classified as a 23S rRNA methyltransferase (Shore et al. 2011). 
Figure 1.1 shows the basic overall structure of the SCCmec element. 
 
Figure 1.1 The base structure of the SCCmec element (adapted from 
http://www.staphylococcus.net) 
 
The 21-67 kb SCCmec element is a core component prone to genetic exchange between 
staphylococci (Hanssen & Ericson Sollid 2006). These elements are characterized by the 
presence of two main gene complexes, the mec complex (responsible for conferring resistance 
to methicillin through the mecA gene) and the chromosome cassette recombinase (ccr) gene 
complex, as well as various joining (J) regions (Ito et al. 2009). The core arrangement of the 
element is J3-mec-J2-ccr-J1; however these components can be arranged in various ways to 
form different SCCmec types, making it an ideal tool for epidemiological purposes. Figure 1.2 
shows the detailed structures of SCCmec types I to VIII. 
 
orfX 
J1 J2 J3 





Type 1– 8 
May include resistance 
determining plasmids 
May include resistance 
determining transposons 




Figure 1.2 Specific SCCmec structures of types I to VIII (Source: Ito et al. 2009) 
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1.3.3 ccr complex 
ccr encodes SCCmec specific serine recombinases of the invertase/resolvase family that 
recognize inverted repeats at the ends of the element allowing site- and orientation-specific 
integration and excision from staphylococcal genomes (Hiramatsu et al. 2001; Hanssen et al. 
2004; Turlej et al. 2011). The ccr gene complex has four genes, ccrA, ccrB, ccrC and ccrAA and 
the functions of all but the last have been determined. ccrAA encodes an analogue of ccrA and 
usually occurs upstream from ccrC, but it has not been defined as a unique ccr gene complex 
(Monecke et al. 2011). Based on the combination of ccrA, ccrB and ccrC, two gene complexes 
can be formed: one with a combination of ccrA and ccrB allotypes, or another containing ccrC 
(Turlej et al. 2011). Different combinations of allotypes within these complexes have generated 
nine unique ccr types to date (Table 1.1). Types 1 through 5 have been identified in most 
staphylococci; however type 6 has only been seen in MR-CoNS isolates and type 7 and 8 are 
only found in MRSA isolates (Shore & Coleman 2013). 





SCCmec types carrying the ccr gene 
complexes 
Type 1 A1B1 I, IX 
Type 2 A2B2 II, IV 
Type 3 A3B3 III 
Type 4 A4B4 VI, VIII 
Type 5 C1 V, VII 
Type 6 A5B3 - 
Type 7 A1B6 X 
Type 8 A1B3 XI 
Type 9 C2 XII 
Adapted from Ito et al. (2009) and (Wu et al. 2015) 
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1.3.4 mec complex 
The mec gene complex carries the main resistance determining gene associated with MRSA, 
mecA, as well as two regulatory genes, mecI and mecR1. mecI encodes a transcription 
repressor protein and mecR1 encodes a signal transduction protein. β-lactam antibiotics bind to 
the extracellular penicillin-binding domain of the MecR1 signal transducer which leads to 
autocatalytic cleavage in its cytoplasmic domain. MecR1 then functions as a protease by 
directly or indirectly cleaving any MecI repressor proteins that are bound to the operator region 
of mecA thereby activating transcription of the mecA gene (Hiramatsu et al. 2001). 
In addition to mecA, mecI, and mecR1, one to four copies of insertion sequence (IS431) may be 
present in the mec complex. These elements are responsible for the MRSA characteristic multi-
drug resistant phenotype, by clustering similar IS elements via homologous recombination 
(Hanssen & Ericson Sollid 2006). They also assist in the transfer of genes and plasmids into the 
chromosome (Hanssen & Ericson Sollid 2006). Table 1.2 shows the six currently identified mec 
gene complex classes and how the individual genes are arranged within each class. 
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Table 1.2 Currently identified mec gene complexes 
mec gene 
complexes  
SCCmec types carrying 
the mec gene complexes 
class A IS431-mecA-mecR1-mecI II, III, VIII 
class B IS431-mecA-ΔmecR1-IS1272 I, IV, VI 
class C1 
IS431-mecA-ΔmecR1-IS431 




(IS arranged in the opposite direction) 
V, IX, XII 






Adapted from (http://www.staphylococcus.net) and Hiramatsu et al. (2001). 
1.3.5 Joining regions 
Three distinct joining (J) regions are found within the SCCmec element, arranged in different 
ways depending on the SCCmec type. These regions were initially considered to be junkyard 
regions, but research showed that they may contain additional non-essential resistance 
determining elements, such as pseudogenes, plasmids and transposons (Zhang et al. 2012). 
Variations within J1 to J3 are used to assign SCCmec subtypes. Typically, the J1 region is 
found between the ccr complex and the end of the element, J2 is situated between ccr and mec 
and the J3 region is between the mec complex and orfX (Figure 1.1). Table 1.3 describes the 
additional resistance genes that may be found in the J regions of the SCCmec element. They 
are typically only found in the larger SCCmec types that typically circulate in HA-MRSA strains, 
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such as SCCmec types I, II and III (Turlej et al. 2011) possibly due to the fitness cost associated 
with acquisition of additional genes. 
Table 1.3 Additional resistance elements that may be found in the SCCmec element 
Element Resistance Region of SCCmec 
SCCmec types 
carrying the element 
pUB110 bleomycin; tobramycin J3 IA, II, IVA 
pT181 tetracycline J3 III 
Tn554 erythromycin; streptomycin J2 II,VIII 
ΨTn554 cadmium J2 III 
Tn4001 aminoglycosides mec complex IVc 
Adapted from Turlej et al. (2011) 
1.3.6 SCCmec types 
At least twelve different SCCmec types, shown in Table 1.4, have been identified and described 
to date (Milheirico et al. 2007; Kondo et al. 2007; Ito et al. 2009; Lulitanond et al. 2013; Wu et al. 
2015; http://www.staphylococcus.net). This is based on the combination of different mec and ccr 
gene complexes, of which numerous classes and allotypes have been identified. Several 
subtypes have also been described, based on variations within the J regions of the SCCmec 
element. 
Stellenbosch University  https://scholar.sun.ac.za
13 
 
Table 1.4 The twelve currently published SCCmec types (as of August 2016) 
SCCmec types ccr gene complexes mec gene complexes 
I 1 (A1B1) B 
II 2 (A2B2) A 
III 3 (A3B3) A 
IV 2 (A2B2) B 
V 5 (C1) C2 
VI 4 (A4B4) B 
VII 5 (C1) C1 
VIII 4 (A4B4) A 
IX 1 (A1B1) C2 
X 7 (A1B6) C1 
XI 8 (A1B3) E 
XII 9 (C2) C2 
 
SCCmec types I, II and III were described in 2001 by Ito and colleagues (Ito et al. 2001) and are 
primarily associated with HA-MRSA (Grundmann et al. 2006). They are the largest of the 
SCCmec elements and carry many additional genes, including genes conferring resistance to 
erythromycin, spectinomycin and tetracycline. They also serve as a chromosomal deposit site 
for other resistance genes, and various integrated plasmids (Ito et al. 2001). The presence of 
these SCCmec elements is associated with a slower growth rate and a decrease in fitness in 
the absence of antibiotic pressure (Monecke et al. 2011). SCCmec III was initially reported as 
the largest element (Ito et al. 2001), but was later redefined as a composite of the SCCmec III 
region and another element called SCCmercury, encoding ccrC, a transposon Tn554 and the 
mer operon (Chongtrakool et al. 2006). After this discovery, multiple SCCmec III variants not 
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carrying the SCCmercury element were reported, suggesting that the two elements originated 
independently (Arakere et al. 2009). During this time, the name SCCmercury was changed to 
SCCHg to avoid confusion with SCCmec (Ito et al. 2009). 
SCCmec type IV was the first element identified from CA-MRSA strains. It is smaller than 
SCCmec types I, II and III and commonly devoid of most other resistance genes (with the 
exception of mecA) (Ma et al. 2002). Recently, type IV has started circulating amongst 
healthcare facilities and is no longer a true CA-MRSA type. It is also the most diverse, most 
likely due to its small size, and has at least 8 reported subtypes (Ghaznavi-Rad et al. 2010). 
The description of the small, community associated SCCmec type V isolated in Australia lead to 
the discovery of the ccrC gene. Type V lacks any antibiotic resistance genes except for mecA 
and carries genes for a restriction-modification system that may aid in stabilization of the 
element on the chromosome (Ito et al. 2004). MRSA strains carrying SCCmec IV or V have also 
spread among livestock and are known as livestock associated MRSA (LA-MRSA) (Monecke et 
al. 2011). Interestingly, although they lack multidrug-resistance genes CA-MRSA strains are 
commonly associated with serious necrotizing pneumonia and SSTI due to the carriage of toxin 
genes encoding for Panton-Valentine leucocidin (PVL). Strains that are PVL positive are known 
to be extremely virulent and spread rapidly through communities (Monecke et al. 2011). 
Strain HDE288, the model for the “pediatric” MRSA clone that originated in hospitals in Portugal, 
was found to contain SCCmec type VI. Type VI was originally misclassified as a variant of type 
IV, but further studies revealed that it had a different ccr allotype, ccrAB4, which lead to its 
reclassification (Oliveira et al. 2006). 
SCCmec type VII is suspected to be a community-acquired strain. It was detected in Japanese 
CA-MRSA isolates and described as a smaller element, similar in size to type IV and V and 
carrying a mec class C1, previously only found in S. haemolyticus (Berglund et al. 2008). 
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SCCmec type VIII was identified in a hospital associated Canadian epidemic MRSA isolate. 
Complete sequence data of this element revealed it was possibly generated through 
recombination with a S. epidermidis strain (Zhang et al. 2009). 
In 2011, two novel SCCmec types, IX and X, were identified in LA-MRSA strains of the clonal 
complex 398. These strains were found primarily in pigs, as well as other livestock and 
individuals who had contact with them. This indicates that there is a true reservoir of MRSA 
strains circulating amongst livestock. SCCmec types IX and X were also found to harbour genes 
allowing detoxification of heavy metals (Li et al. 2011). SCCmec type XI was first sequenced by 
the Sanger Institute from the bovine MRSA strain LGA251 (sequence type 425) in England 
(Shore & Coleman 2013). This SCCmec type is very unusual due the presence of highly 
divergent mecA, mecI, mecR1, blaZ, and ccr genes. An arsenic resistance gene was also 
identified, which is particularly interesting as this gene has not previously been found in 
association with SCCmec, but has been seen in CoNS, MSSA, Escherichia coli, and 
Pseudomonas fluorescens (Shore et al. 2011). 
Types IX and X share some of the features of type XI that may give clues to the origin of 
SCCmec. All three are considered to be from MRSA strains of animal origin and they carry 
genes encoding resistance to heavy metals. In addition, the divergent structure of SCCmec type 
XI suggests that it evolved in a different species or genus, and that it possibly contains ancestral 
forms of the gene complexes of SCCmec (Shore & Coleman 2013). 
The most recent SCCmec type contained a novel ccrC2 gene, which was found to be widely 
spread in CoNS isolates, but also seen in other staphylococcal isolates from China, France, 
Germany and the United States. This element was also flanked by a pseudo (Ψ) SCC element 
(SCC element lacking a functional mec or ccr gene) (Wu et al. 2015). 
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1.4 Molecular SCCmec typing methods 
Being able to assign a SCCmec type correctly is an important requirement for epidemiological 
studies. SCCmec typing can also be utilized for the investigation into the origin and evolution of 
contemporary MRSA clones that have disseminated globally (Turlej et al. 2011). There are four 
approaches to molecular typing of the SCCmec element: restriction enzyme digestion, multiplex 
PCR (mPCR), real-time PCR and sequencing. Typing with the use of mPCRs is the most 
popular and economical of all four methods, however classification based on band sizes alone, 
may be misleading. Therefore sequencing the entire element remains the gold standard for 
typing, especially when characterizing a novel element. Unfortunately, sequencing is relatively 
expensive and the subsequent data analysis is complicated. As a result mPCRs are usually 
completed first to assess the need for sequencing. Below we summarize the existing mPCR 
approaches and how they have evolved. 
Several mPCR based typing schemes have been designed for the identification of SCCmec 
elements in clinical S. aureus isolates and also for the sub-typing of some SCCmec types. 
These mPCRs are tools that type based on unique DNA band patterns observed by gel 
electrophoresis. The first known attempt was made by Oliveira and de Lencastre (2002). At the 
time of publication, only SCCmec types I to IV were described in the literature and the mPCR 
was designed to detect all of them as well as a few subtypes of I and III. 
Shortly after this, a Canadian research team developed a new single assay to classify the types 
and subtypes I, II, III, IVa, IVb, IVc, IVd and V (Zhang et al. 2005). In addition to the first 
reaction, two other multiplex PCRs were designed to characterize the mec and ccr gene 
complexes; and a uniplex PCR to assign ccr 5. While it was more accurate and descriptive than 
the original mPCR designed by Oliveira et al. (2002) the multiple reactions necessary for full 
characterization were labor-intensive and therefore not suited for larger sample numbers. 
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Boye et al. (2007) developed a simpler mPCR using only four primer pairs that was able to 
distinguish between the five main SCCmec types described at the time. However, in light of the 
discovery of type VI and multiple subtypes of type IV, this method was rapidly considered 
outdated. In addition, Oliveira’s group published an update to their mPCR strategy in 2007, 
which was able to identify and discriminate between types I to VI (Milheirico et al. 2007). This 
method is rapid and robust and it detects all the major HA-MRSA types that have spread across 
healthcare facilities and communities across the world. A mPCR very similar to the Milheirico 
method (Milheirico et al. 2007) was developed in 2010 that has the ability to better distinguish 
subtypes of type IV, however it shows no other significant advantage as a typing strategy 
(Ghaznavi-Rad et al. 2010). 
A major breakthrough for SCCmec type assignment came with the design of six unique mPCRs 
by Kondo et al. (2007). Since this approach does not target specific SCCmec types, but rather 
specific loci, the first two mPCRs alone are potentially able to classify SCCmec types I to XI, 
with the exception of types VII and X. In most cases, this should be sufficient for epidemiological 
purposes (Turlej et al. 2011). When the last four mPCRs are added, a large variety of subtypes 
and the presence of additional resistance determining elements can be identified. 
Chen et al. (2009) developed a multiplex real-time PCR for SCCmec typing using molecular 
beacons. The advantages of such an assay are the high sensitivity, reduced downstream 
analysis and lower risk of amplicon contamination. Up to 96 isolates can be typed within 4 
hours. Unfortunately this assay was only designed to detect SCCmec types I - VI and VIII and is 
not suitable for subtyping. Molecular beacon probes are also more expensive in comparison to 
traditional PCR methods and are only cost-effective when used in bulk. 
In summary, while many different PCR methods have been designed as strategies to type 
SCCmec elements, they do not perform equally or generate corresponding data (Ghaznavi-Rad 
et al. 2010). So far, the assay described by Kondo et al. (2007) is the most complete typing 
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scheme, however, since more than one mPCR reaction is required, it can become time 
consuming. To save time and streamline the typing process, a combination of the Milheirico 
(2007) and Kondo (2007) protocols may prove more effective. Initial screening done by the 
Milheirico (2007) protocol should be able to type the bulk of the isolates, since it types the main 
circulating strains seen worldwide. The Kondo (2007) protocol can then be reserved for cases 
where Milheirico (2007) is unable to assign a type, or unusual band patters are observed. 
If molecular typing by means of PCR reveals a potential novel SCCmec type or subtype, it is 
essential to determine the entire nucleotide sequence of the SCCmec element by sequencing. 
The SCCmec element must be analyzed to prove the presence of novel DNA sequences in, or 
combinations of the characteristic genes, pseudogenes and other noncoding regions (J 
regions). Secondly, mobile elements, mostly those that provide resistance to antimicrobials, 
such as plasmids, transposons or insertion sequences, must also be present in the J region. In 
addition, studying the genome may give insight into possible horizontal gene transfer (HGT) 
events, and how the SCCmec element continues to gain resistance to numerous antibiotics and 
heavy metals (Kuroda et al. 2001). 
Owing to the ongoing confusion around SCCmec nomenclature, the International Working 
Group for SCCmec (IWG-SCC, http://www.staphylococcus.net) was formed to provide 
consensus guidelines for nomenclature and to establish minimum standards for identifying new 
SCCmec types. It is recommended that all new putative SCCmec types, along with accession 
numbers be submitted to the IWG for review and allocation of a name (Ito et al. 2009). 
1.5 MR-CoNS 
1.5.1 Clinical significance of MR-CoNS 
Staphylococci are classified into two major groups, namely coagulase-positive staphylococci, 
represented almost exclusively by S. aureus; and coagulase-negative staphylococci (CoNS). All 
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staphylococci readily colonize the human skin and mucous membranes as opportunistic 
pathogens, but the ability of CoNS to cause infection is much less than that of S. aureus (Shore 
& Coleman 2013). However, the increasing number of vulnerable population groups, including 
the elderly, premature neonates and immunocompromised persons; is increasing the clinical 
significance that these organisms have (Becker et al. 2014). The ability of the most common 
member of the CoNS, S. epidermidis, to form biofilms is especially worrying in neonatal 
intensive care unit (NICU) settings (Becker et al. 2014). Furthermore, the levels of antibiotic 
resistance in hospital CoNS populations (specifically towards methicillin) are very high and can 
be upwards of 60% (Barbier et al. 2010). Further, CoNS commonly present with multidrug 
resistant phenotypes that dramatically increase morbidity in nosocomial infections (Widerström 
2016). 
Research done with clinical specimens suggest that MR-CoNS may act as a reservoir of 
SCCmec elements or their individual components (Bouchami et al. 2011). Although the 
mechanism for the transfer of SCCmec from MR-CoNS to methicillin-sensitive S. aureus 
(MSSA) is yet to be determined, the hypothesis is that horizontal gene transfer (HGT) occurs 
between commensal CoNS and MSSA leading to the evolution of MRSA (Hanssen & Ericson 
Sollid 2006; Barbier et al. 2010). 
1.5.2 SCCmec types in MR-CoNS 
Methicillin-resistant coagulase-negative staphylococci (MR-CoNS) have a more divergent 
SCCmec structure than other staphylococcal species, contain ccr-mec combinations that are 
not found in MRSA, and also have untypeable ccr allotypes (Ruppé et al. 2009). This diversity, 
along with a lack of a numbering system specific for CoNS hampers molecular typing of the 
SCCmec in species belonging to this group. SCCmec types II, III, IV and V which are found in 
MRSA are also very common in CoNS, however combinations of these types are abundant and 
no typing schemes have been developed to properly classify them (Zong et al. 2011). In 
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addition to the interesting SCCmec combinations, some elements may even lack one or both of 
the two major gene complexes, ccr and mec. Some S. hom. hominis and S. haemolyticus 
strains have been reported to have non-mecA SCCmec elements. These and other ΨSCC 
elements such as the arginine catabolic mobile elements (ACMEs) are common amongst CoNS 
(Becker et al. 2014). 
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1.6 Problem statement 
In South Africa, there is a lack of data concerning the molecular epidemiology of MRSA (Jansen 
van Rensburg et al. 2011). The majority of the existing data originates from the Gauteng and 
KwaZulu-Natal provinces (Moodley et al. 2010) and is outdated. Recent studies done at 
Tygerberg Academic Hospital, Cape Town, suggest a high prevalence of multidrug resistant 
MRSA (Oosthuysen 2013), which demonstrates that further studies addressing the molecular 
epidemiology of MRSA are necessary in our setting. In addition, preliminary data generated in 
our laboratory suggests that the largest cluster of our MRSA isolates from blood culture 
specimens (34%) may contain a novel SCCmec type (Karayem 2014). Furthermore, this study 
also identified a potentially novel variant of SCCmec type I in 17% of the isolates. Initial typing 
using multiplex PCR (Milheirico et al. 2007) suggests that the novel variant consists of ccrC and 
ccrA1B1 with a class B mec gene. This novel SCCmec type was also identified in a S. capitus 
isolate, suggesting that this novel type may have evolved from CoNS. We believe that the novel 
SCCmec may be a combination of a Class A mec and ccrC (Type 5A). These novel and novel 
variant SCCmec types therefore warrant further characterization. 
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Aims and Objectives 
We aimed to describe the epidemiology and genotypic characteristics of MRSA and CoNS 
strains isolated at Tygerberg Hospital, South Africa, with a specific focus on determining the 
prevalence, source and full genetic characterization of a potentially novel SCCmec type. 
We hypothesized that this SCCmec type was indeed novel and resulted from horizontal gene 
transfer from CoNS strains. 
Aims 
1. To fully characterize the novel and novel variant SCCmec elements. 
2. To describe the epidemiology and SCCmec types present in methicillin-resistant CoNS 
strains isolated at Tygerberg Hospital, South Africa. 
Objectives 
1. To provisionally characterize the novel and novel variant elements and confirm the 
presence of generic regions using multiplex PCR assays. 
2. Based on the results of Objective 1,  
a. Review the SCCmec typing results of isolates stored during the course of 
previous studies to determine whether the novel or novel variant SCCmec types 
were present in older isolates. 
b. Perform SCCmec typing on a collection of MR-CoNS isolates in order to 
determine whether the novel and/or novel variant SCCmec types were present in 
local CoNS isolates. 
c. Perform next-generation sequencing (NGS) analysis on a selected subset of 
isolates to characterize the structure of the novel and novel variant SCC 
elements. 
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Chapter 2: The SCCmec typing of MRSA and MR-CoNS isolates 
according to the method of Milheirico et al. 2007 
2.1 Introduction 
Methicillin resistant Staphylococcus aureus (MRSA) is an increasing problem in hospitals and 
causes an increase in morbidity and mortality associated with staphylococcal infections. 
Methicillin resistant coagulase negative staphylococci (MR-CoNS) are also commonly isolated 
in hospital settings, and epidemiological studies show that methicillin resistance rates in 
healthcare settings were higher than 70% (Diekema et al. 1999; Decousser et al. 2015). The 
clinical impact of high resistance rates in CoNS remains unclear, because it is difficult to 
distinguish between contamination and true infection in CoNS cases (Tashiro et al. 2015). 
The core MGE responsible for methicillin resistance in staphylococcal species is the SCCmec 
element. In MRSA these elements have characteristic structures that can be used for 
epidemiological typing. Along with MLST (multi locus sequence typing), spa typing and PFGE 
(pulsed-field gel electrophoresis), SCCmec typing is an essential tool in the identification of the 
diversity and mechanism of transmission of MRSA clones amongst populations. Currently, there 
are 12 SCCmec types and multiple subtypes described in the literature. Many SCCmec typing 
schemes exist, but most are laborious and time-consuming to perform. The multiplex PCR 
(mPCR) assay described by Milheirico and colleagues (Milheirico et al. 2007) is a relatively fast 
way of screening MRSA isolates for the most common SCCmec types (I to VI).  
The purpose of this study was to investigate putative novel and novel variant SCCmec types 
previously found in our setting by performing molecular typing using the Milheirico (2007) 
protocol. We also screened prospectively collected MR-CoNS isolates to determine whether this 
population harboured the novel elements as suggested by the discovery of the novel type in a 
S. capitus isolate. 




2.2.1. Sample selection 
Staphylococcus aureus We planned to investigate 90 MRSA isolates (from blood cultures and 
nasal swabs) that had been stored from 2010 to 2011 as part of the previous study which first 
identified the putative novel and novel variant SCCmec types (Karayem 2014). Of the 90, 87 
were viable and were included in this study. 
Coagulase negative staphylococci 
Four hundred seventy CoNS isolates from blood cultures processed by the National Health 
Laboratory Service (NHLS) microbiology laboratory, Tygerberg, were prospectively collected 
and stored. These blood cultures were taken as part of routine patient care. Isolates were 
identified and susceptibility profiles determined by the routine Standard Operating Procedures 
(SOPs) of the NHLS. This included Gram staining, catalase, DNase (DNA hydrolysis) tests, 
Pastorex Staph Plus (Bio-Rad, South Africa) rapid agglutination test and culture on MSA 
(mannitol salt agar) to distinguish between S. aureus, CoNS and other Gram positive 
organisms. The majority of CoNS isolates were not considered to be clinically significant (i.e. 
most likely skin contaminants) and therefore species identification was not done. Of the 470 
collected isolates, 170 randomly selected isolates were screened for methicillin resistance and 
total of 100 methicillin resistant isolates were identified.. 
Selected patient data on all samples were collected including age and gender of the patient and 
from which ward the sample was sent. This study was approved by the HREC (Health Research 
Ethics Committee) of Stellenbosch University with the approval number S15/03/065. 
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2.2.2. Sample storage 
Microbank Tubes (Pro-Lab Diagnostics) were used for sample storage. Each tube contains 20 
to 30 sterile beads along with a cryopreservative, which allows long term storage of isolates 
at -70 to -80°C. A loop full of colonies from pure overnight cultures (MSA plates, NHLS Media 
Laboratory, South Africa) was inoculated on solid horse blood agar (NHLS Media Laboratory, 
South Africa). The tubes were then inverted 4 to 5 times to emulsify the organisms and 
incubated at room temperature (25°C) for 2 minutes. After incubation a pipette with a sterile, 
disposable tip was used to remove as much of the cryopreservative as possible. The tubes were 
then stored at -70 to -80 °C. 
2.2.3. Cefoxitin screening of CoNS isolates 
Stored CoNS samples were phenotypically screened for methicillin resistance to select a total of 
100 MR-CoNS isolates for molecular SCCmec typing. Following the Clinical and Laboratory 
Standards Institute standards (CLSI 2013), the cefoxitin (FOX) disk diffusion test was used 
instead of oxacillin. FOX is a stronger inducer of the mecA gene than oxacillin and therefore 
produces more accurate results. 
Selected isolates were subcultured onto blood agar from single Microbank beads and incubated 
at 37° C for 18 to 24 hours. Four to five colonies were re-suspended in up to 5 mL of saline to 
produce a McFarland standard of 0.5. A sterile swab was used to inoculate the suspension onto 
the surface of Mueller-Hinton agar plates (NHLS Media Laboratory, South Africa) and once the 
plates had dried, 30 µg FOX disks (MAST Diagnostics, UK) were placed in the centre of each 
plate using a sterile needle. The plates were incubated aerobically for 24 hours at 37°C, after 
which the inhibition zone diameters were measured. The disk diffusion results were interpreted 
using published CLSI criteria to determine FOX resistance in CoNS species, where an inhibition 
zone of ≥ 25 mm is considered to be sensitive and ≤ 24 mm is resistant (CLSI 2013). 
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2.2.4. Speciation of MR-CoNS isolates 
To gain a better idea of the range of different species in our MR-CoNS population, the MR-
CoNS isolates were speciated using the VITEK®2 system (bioMérieux, South Africa). This is an 
automated biochemical identification platform which uses Advanced Colorimetry™ to detect the 
results of multiple biochemical tests on specific identification (ID) or antimicrobial susceptibility 
test (AST) cards. The assay was done according to the NHLS standard operation procedure 
(SOP) for the VITEK®2. Individual test results were indicated as “+” (positive), “-” (negative) or 
“?” (weak reaction) and analysed by the software to give an organism ID within 4 to 6 hours. 
2.2.5. DNA extraction of MRSA and MR-CoNS isolates 
A crude boil method was implemented for DNA extraction of stored organisms. A Microbank 
bead was plated onto a blood agar plate and incubated at 37 °C overnight. After incubation, 
plates were inspected and four to five colonies were selected and re-suspended in 200 µL of 
nuclease free water in 1.5 mL microcentrifuge tubes. Nuclease free water was used as a cost-
effective alternative for Tris-EDTA (TE) buffer, since it was observed that the DNA remained 
stable during storage at -20°C. The tubes were incubated at 95°C for 30 minutes, followed by 
incubation at -80°C for another 30 minutes. Tubes were allowed to thaw at room temperature 
(25°C) and then centrifuged for 10 minutes at 14000 x g. The supernatant containing the DNA 
was aliquoted to avoid freeze-thaw induced DNA degradation and stored at -20° C until further 
use. Samples were spun down for 3 minutes at 14000 x g before each PCR to pellet any cell 
debris. 
2.2.6. Milheirico mPCR on MRSA and MR-CoNS isolates 
SCCmec typing was performed on all stored MRSA isolates using the multiplex PCR (mPCR) 
method previously described by Milheirico et al. (2007). This was done to confirm previous 
SCCmec typing performed on these isolates (Karayem 2014). The mPCR used 20 different 
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primers (Integrated DNA Technologies, South Africa) (listed in Table 2.1) to amplify specific 
targets within the SCCmec element. These included sequences in the mec gene and ccr gene 
complex, and the joining regions J1 and J3 and an internal control target, mecA (162 bp), to 
validate each reaction and to confirm methicillin resistance. The combination of these targets 
was used to classify isolates into SCCmec types by comparing their band patterns to those of 
reference strains (Table 2.2) as shown previously (Milheirico et al. 2007). A no template control 
(NTC) with nuclease free water was added to each PCR run to determine possible 
contamination. 
Briefly, each reaction contained 1 µL of template DNA, 1X KAPA 2G Fast Multiplex Mix (KAPA 
Biosystems, South Africa), the ten sets of primer pairs with concentrations shown in Table 2.1 
and nuclease-free water to bring to volume (25 µL). 
Amplification consisted of an initial denaturing step at 95°C for 3 minutes, followed by 30 cycles 
of denaturation at 95°C for 15 seconds, annealing at 60°C for 30 seconds and elongation at 
72°C for 45 seconds. A final extension step at 72°C for 3 minutes concluded the PCR. Samples 
were held at 4°C until further use. 
Amplification products (for expected sizes, please refer to Table 2.1) were visualized on 3% 
SeaKem LE Agarose (Lonza, South Africa) gels in tris-acetic acid-EDTA (TAE) buffer. The 
KAPA Universal DNA Ladder (KAPA Biosystems, South Africa) was used for band size 
reference (Addendum A: Materials). Gels were loaded with a mixture of 10 µL of sample/ladder 
and 2 µL of NovelJuice (GeneDireX, South Africa) loading dye, a non-toxic alternative to 
ethidium bromide staining (Addendum A: Materials). The gels ran for 70 to 80 minutes at 10 - 12 
V/cm using the PowerPac Basic power supply system (Bio-Rad, South Africa) and amplicon 
bands were visualised with the UVItec Alliance 2.7 gel documentation system (UVItec, UK) and 
compared to the six reference SCCmec strains (Table 2.2). 
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Table 2.1 List of primers used for the Milheirico (2007) protocol 







II; J1 284 
0.2 µM 
kdpR1 CGAATGAAGTGAAAGAAAGTGG 0.2 µM 
CIF2 F2 TTCGAGTTGCTGATGAAGAAGG 
I; J1 495 
0.4 µM 
CIF2 R2 ATTTACCACAAGGACTACCAGC 0.4 µM 
RIF5 F10 TTCTTAAGTACACGCTGAATCG 
III; J3 414 
0.4 µM 
RIF5 R13 GTCACAGTAATTCCATCAATGC 0.4 µM 
SCCmec III J1 F CATTTGTGAAACACAGTACG 
III; J1 243 
0.4 µM 
SCCmec III J1 R GTTATTGAGACTCCTAAAGC 0.4 µM 
SCCmec V J1 F TTCTCCATTCTTGTTCATCC 
V; J1 377 
0.4 µM 
SCCmec V J1 R AGAGACTACTGACTTAAGTGG 0.4 µM 
mecI P2 ATCAAGACTTGCATTCAGGC 
II, III; mec 209 
0.8 µM 
mecI P3 GCGGTTTCAATTCACTTGTC 0.8 µM 
dcs F2 CATCCTATGATAGCTTGGTC 
I, II, IV, VI; J3 342 
0.8 µM 
dcs R1 CTAAATCATAGCCATGACCG 0.8 µM 
mecA P4 TCCAGATTACAACTTCACCAGG 
Internal control 162 
0.8 µM 
mecA P7 CCACTTCATATCTTGTAACG 0.8 µM 
ccrB2 F2 AGTTTCTCAGAATTCGAACG 
II, IV; ccr 311 
0.8 µM 
ccrB2 R2 CCGATATAGAAWGGGTTAGC 0.8 µM 
ccrC F2 GTACTCGTTACAATGTTTGG 
V; ccr 449 
0.8 µM 
ccrC R2 ATAATGGCTTCATGCTTACC 0.8 µM 
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Table 2.2 Reference strains used in the Milheirico (2007) protocol 
SCCmec type Reference Strain Origin 
I BAA-38 ATCC (American Type Culture Collection) 
II BAA-1681 ATCC 
III BAA-39 ATCC 
IV BAA-1680 ATCC 
V WIS Division of Medical Microbiology, University of 
Cape Town 
V BAA-1688 ATCC 
VI BAA-42 ATCC 
 
  




2.3.1. Cefoxitin screening of CoNS isolates 
One hundred seventy of the 470 CoNS isolates collected were screened for methicillin 
resistance using the cefoxitin (FOX) disk diffusion test. 40.6% (69/170) were FOX sensitive, 
58.8% (100/170) were FOX resistant and a single isolate was deemed non-viable after repeated 
attempts to culture from Microbank beads. The average inhibition zone was 31 mm for the 
sensitive isolates and 16 mm for the resistant isolates. An example of a resistant isolate is 
shown in Figure 2.1. 
 
Figure 2.1 A MR-CoNS isolate as determined by the cefoxitin disk diffusion test. The 
arrow shows how the zone of inhibition zone was measured. 
2.3.2. VITEK®2 speciation of MR-CoNS isolates 
A total of 100 MR-CoNS samples were collected of which 19 were previously identified (18 S. 
epidermidis, 1 S. capitis). We identified the remaining 81 isolates with the VITEK®2 
(bioMérieux, South Africa) automated analyser. As shown in Figure 2.2, methicillin resistance in 
our isolates is spread across a wide range of CoNS species commonly found in humans, of 
Inhibition zone (mm) 
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which S. epidermidis, S. haemolyticus and S. hom. hominis form the majority. The VITEK®2 
(bioMérieux, South Africa) was not able to discriminate between two or more species and 
identify 5% of the isolates. 
 
Figure 2.2 Species variation of 100 MR-CoNS samples. Species were identified using the 
VITEK®2 (bioMérieux, South Africa) automated system. The majority of the isolates were 
identified as S. epidermidis, S. haemolyticus and S. hom. Hominis. The prevalence of S. 
warneri, S. saprophyticus and S. capitis were very low. Five isolates could not be identified. 
2.3.3. Milheirico mPCR (MRSA isolates) 
We performed molecular typing of 87 viable retrospective MRSA isolates, using the Milheirico 


















Figure 2.3 SCCmec typing. The results of molecular SCCmec typing on 87 MRSA isolates are 
shown. The majority of the isolates belonged to the N (orange), type IV (green) and NV (purple) 
groups. Types III and II (red and blue respectively) had lower prevalence and only one type V 
isolate was found. No SCCmec type I or VI isolates were identified. 5% of the isolates were 
untypeable by current methods (yellow). 
 
The putative novel and novel variant SCCmec elements in our MRSA isolates represent 36% 
and 17% of the population respectively. The rest of the population comprised of SCCmec types 
IV (24%), III (11%) and II (6%). 
Initially, we used strain BAA-1688 as a reference and control for SCCmec type V (Table 2.2), 
however after close inspection of the band patterns, we determined that this strain does not 
amplify the 377 bp SCCmec V J1 target. We performed a uniplex PCR for this target in BAA-
1688, which was unsuccessful (results not shown). The Division of Medical Microbiology, 
University of Cape Town (C Moodley) kindly supplied us with an alternative SCCmec type V 
strain, WIS, and we compared the two strains (Figure 2.4) showing successful amplification of 



















Figure 2.4 Milheirico mPCR. A comparison between two SCCmec type V reference strains, 
BAA-1688 and WIS, and a Type V variant isolate from our study. A DNA marker (ladder) and 
NTC were included. 
BAA-1688 is possibly a type V variant missing the J1 region, as is the type V isolate that we 
typed, but further investigation will be necessary to confirm this. We continued the rest of the 
study using strain WIS as the control strain for SCCmec type V. 
Figure 2.5 shows a typical SCCmec typing result for the Milheirico (2007) protocol. 




Figure 2.5 Milheirico mPCR results. Six controls and a number of representative isolates are 
shown in this summary gel, along with a NTC (no template control) and DNA markers (Ladders) 
to estimate band size. 
 
Lanes 2 – 7 show the six controls that were included in each run for band pattern comparison. 
The type III control also contains the 449 bp product, ccrC, which is an indication that it may 
carry the SCCHg element. Lane 8 shows the novel type (N), which had a similar pattern to type 
III, with the absence of the J1 band (243 bp). The novel variant (NV, Lane 9) had a band pattern 
identical to type I with the addition of a product resembling ccrC (449 bp). One type V isolate 
was identified and it shared the band pattern of the type V control, BAA-1688 (Figure 2.4). Type 
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I and Type VI were not observed. Of the 87 isolates, 5% were untypeable and a single isolate 
had a failed PCR reaction. 
2.3.4. Milheirico mPCR (MR-CoNS isolates) 
In addition to the molecular typing of our MRSA isolates, we also typed all 100 of our MR-CoNS 
isolates. A typical mPCR result for MR-CoNS isolates is shown in Figure 2.6. 




Figure 2.6 Milheirico mPCR on MR-CoNS isolates: A. Six controls and five isolates are 
shown, including DNA markers (Ladders); B. Additional isolates from the same PCR are shown, 
along with DNA markers (Ladders) and an NTC (no template control). 
 
Some non-specific binding was observed around the largest targets for the controls of SCCmec 
type III, V and the novel and novel variant types. However, this did not impact on typing, since 
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each type still showed a unique band pattern. The CoNS isolates showed a more diverse set of 
SCCmec elements, and the majority (57%) could not be assigned by the standard MRSA 
SCCmec typing scheme. A largest typeable subset of the MR-CoNS isolates were type IV 
(35%), followed by type I (4%) and type V (3%, similar to the variant BAA-1688). Only one 
isolate carried the novel type. As shown in Figure 2.6 A (Lane 14) and B (Lanes 3, 6, 7), another 
SCCmec type I-variant was found in our CoNS population that differs from the novel variant 
found in the MRSA group, as it no longer has amplification in the J3 region as seen in type I, but 
has a band corresponding to ccrB2, which is present in types II and IV, and does not seem to 
carry the ccrC gene found in the MRSA novel variant. No novel variant band patterns were 
observed in any of the MR-CoNS isolates and only a single isolate was found with the novel 
band pattern identified in the MRSA group. Two SCCmec type V variants were found that were 
similar in band pattern to BAA-1688. A small number of CoNS isolates (11%) only had 
amplification of the internal control (mecA) and three non-mecA isolates (with amplification of 
other targets) were identified. 
  




2.4.1. MR-CoNS screening and speciation 
The levels of methicillin resistance in our CoNS population (58.8%) were much lower than 
expected, since CoNS are often reported to have higher methicillin resistance rates than S. 
aureus, with levels ranging from 75% to as high as 90% (Diekema et al. 1999; Garza-González 
et al. 2010; Decousser et al. 2015). Mert et al. (2011) found that methicillin resistance levels in 
CoNS isolated from blood cultures is lower in true bacteraemia compared to contaminants. 
CoNS identified from blood culture are only considered to be significant if they are isolated from 
two or more consecutive blood cultures within a 24 hour period (Bekeris et al. 2005). However, 
our set of isolates effectively represents a convenience sample, and we do not know whether 
the CoNS in our sample were clinically significant or not, since the clinical data were not 
available for this study. A more stringent isolate and data collection strategy will allow the 
researcher to differentiate between true pathogens and contaminants and therefore give a more 
accurate clinical picture of methicillin resistance in CoNS populations. These strategies require 
intensive data capturing of blood cultures to determine the time samples were collected or 
registered in order to ensure the criteria for clinical significance is met. Furthermore, the clinical 
findings of physicians may be compared to the blood culture results.  
The three most commonly isolated CoNS species from humans, S. epidermidis, S. haemolyticus 
and S. hom. hominis formed the majority of our MR-CoNS population. A small percentage of the 
isolates had identification results with low discrimination between two or more species which 
can be an indication of mixed cultures. Further analysis via a β-Glucosidase (bGLU) test is 
necessary to determine the species. Mixed cultures are a common problem during CoNS 
collection and storage, since it is challenging to differentiate between CoNS species directly 
from culture plates. They can become confounding in downstream reactions, especially if 
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culturing is done multiple times for different experimental procedures. To avoid this, it is 
essential to subculture from a single colony before storage on Microbank beads. 
2.4.2. Multiplex PCR troubleshooting 
Multiplex PCRs (mPCRs) such as the Milheirico (2007) protocol are useful epidemiological 
tools, since they can identify multiple targets from a single organism or range of different 
organisms. The majority of SCCmec typing schemes rely on the use of mPCRs. However, the 
nature of these mPCRs can make it difficult to optimize and to interpret results, as they produce 
multiple targets that are often similar in size and are therefore easily confused. It is essential to 
find the correct balance of PCR reaction components and thermocycling conditions to produce 
the selected PCR targets. One of the biggest problems of mPCRs is finding the ideal annealing 
temperature. Using an annealing temperature of 5 degrees below the primer’s melting 
temperature (Tm) is usually sufficient for uniplex PCRs, but the presence of multiple primers may 
cause complications. If the annealing temperature is too low, non-specific bands may appear, 
and higher temperatures can cause some target regions to fail during amplification. 
Troubleshooting includes running the PCR at a range of different annealing temperatures to find 
the best result. In addition, the concentration of primers and MgCl2 can be adjusted to optimize 
the PCR reaction once the ideal annealing temperature has been selected. 
Agarose gel electrophoresis conditions can also adversely affect the interpretation of results if 
they are not set up correctly. The gel concentration, runtime and voltage need to be selected 
according to the number and size of the expected targets. Visual inspection of gel pictures at 
different time points will assist in the selection of the ideal runtime. Targets that range from 200 
bp to 1000 bp in size can be run on 2% agarose gels. Targets smaller than 200 bp will have 
better separation on more concentrated gels (3%) and targets larger than 1000 bp will separate 
better on less concentrated gels (1.5%). The targets in the Milheirico (2007) protocol only range 
from 160 bp to 500 bp in size, however the high number of targets and similarities in target sizes 
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require a 3% gel for separation of targets to be acceptable for interpretation. Running gels for 
short periods of time can cause misinterpretation of targets and consequently incorrect type 
assignment. Software is available for cases where manual analysis may lead to error, for 
example extremely small base pair differences (<10 bp) between targets. 
2.4.3. Milheirico mPCR on MRSA and MR-CoNS isolates 
The advantage of using the Milheirico (2007) protocol for SCCmec typing is the short time-to-
completion, which is approximately four hours, including DNA extraction. However, if samples 
are not batched, it can become laborious and expensive since each run requires the addition of 
six SCCmec controls. The protocol may therefore be more useful in settings where an existing 
collection of isolates will be screened, rather than ad hoc screening. Questions may be raised 
over the relevance of this protocol, since there are already 12 SCCmec types described in the 
literature, and this assay is only designed to assign SCCmec types I to VI. However, SCCmec 
types I to V are the types found in healthcare facilities globally, whereas types VI to XII are 
either local or livestock-associated types that are not connected to globally spread clones. 
In our setting, the Milheirico (2007) protocol proved to be an ideal screening tool that identified 
both medically relevant SCCmec types and revealed possible novel and novel variant types. 
Isolates that cannot be typed with this protocol, can be investigated further using more 
comprehensive typing schemes, such as the one developed by Kondo et al. (2007). 
While the Milheirico (2007) protocol is an effective screening tool for SCCmec types in MRSA 
isolates; its utility for MR-CoNS species is limited by their large diversity and the divergent 
structures of their SCCmec types. This highlights the need for a structured SCCmec typing 
scheme for CoNS species (Zong et al. 2011). The diversity and high rates of resistance in MR-
CoNS suggest that they may be a reservoir for SCCmec types and facilitate the formation of 
new SCCmec types (Hanssen & Ericson Sollid 2007). The suggested mechanism for the 
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formation of new SCCmec types is horizontal gene transfer (HGT) between staphylococcal 
species (Hanssen & Ericson Sollid 2007; Garza-González et al. 2010; Mert et al. 2011; Zong et 
al. 2011). This does not appear to be the case for the origin of the novel and novel variant 
SCCmec types identified in our MRSA population. The novel and novel variant were similar to 
SCCmec types III and I respectively and together with SCCmec type III they formed the majority 
of our MRSA population. Conversely, screening of the MR-CoNS population did not identify the 
novel variant SCCmec element or SCCmec type III, and only a single novel SCCmec element. 
This suggests that the novel elements may have evolved by transmission and/or recombination 
events within the MRSA population and not through HGT between species. 
In our study, the majority of MR-CoNS isolates were untypeable by the conventional SCCmec 
typing schemes and mainly carried combinations of published types or had uncharacterized 
band patterns. A small number of CoNS isolates (11%) only had amplification of the internal 
control (mecA), which may be an indication of truncated SCCmec elements or sequence 
changes in the ccr complex, which is known to be the most diverse in MR-CoNS isolates (Zong 
et al. 2011). Three non-mecA isolates (with amplification of other targets) were also identified, 
indicating that an alternative mechanism of methicillin resistance may be present in these 
isolates. 
Among the typeable isolates, the most common SCCmec type found in our MR-CoNS 
population was SCCmec type IV. This is consistent with other published MR-CoNS SCCmec 
typing data (Jamaluddin et al. 2008; Barbier et al. 2010; Garza-González et al. 2010). The 
persistence and dissemination of SCCmec type IV and other smaller elements across both 
MRSA and MR-CoNS populations may be linked to increased mobility and its smaller size 
(Strandén et al. 2009; Barbier et al. 2010; Mert et al. 2011). 




Preliminary SCCmec typing revealed that the largest cluster of MRSA isolates in our setting 
belonged to putative novel and novel variant SCCmec types. We determined that they were 
closely related to SCCmec types III and I, which are associated with HA-MRSA strains. The 
Milheirico (2007) protocol was found to be a suitable screening method; however additional 
typing methods are necessary to effectively characterize the novel and novel variant SCCmec 
types. 
The MR-CoNS population was initially considered to be a reservoir for the novel and novel 
variant SCC elements; however our results showed that the novel types were absent in the MR-
CoNS population. A limitation of this study is that the isolate collection for the MRSA and CoNS 
groups was done at different time points (2010 and 2014, respectively). There is a possibility 
that the novel elements were initially present in the MR-CoNS population, but did not convey 
any evolutionary advantage to the MR-CoNS population, and were therefore lost. It may also be 
useful to investigate whether the novel elements are still present in the current MRSA 
population. 
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Chapter 3: The SCCmec typing of MRSA and MR-CoNS isolates 
according to the method of Kondo et al. 2007 
3.1 Introduction 
The Milheirico (2007) protocol has been shown to be efficient in screening large numbers of 
isolates for the most common SCCmec types, however many isolates may not fit the patterns 
produced by this assay and need to be characterized in more detail. This requires each region 
in the element to be targeted separately, and the method should distinguish differences down to 
subtype level. One such tool is the SCCmec typing assay developed by Kondo et al. (2007). 
While this protocol is more time-consuming and labour-intensive than other typing methods 
such as the Milheirico (2007) protocol, it provides much more detailed information about 
SCCmec types and subtypes. The Kondo (2007) protocol includes the use of six multiplex 
PCRs (mPCRs) which assign ccr complex types and mec classes, and targets various Open 
Reading Frames (ORFs) and resistance determinants in the J1, J2 and J3 regions, thereby 
allowing subtype determination of SCCmec types II and IV. 
The aim of this study was to characterize the novel and novel variant isolates found in our 
MRSA and MR-CoNS population in more detail, by optimizing and implementing the Kondo 
(2007) protocol on a selection of representative isolates.  




3.2.1 Sample selection 
We confirmed the presence of a putative novel and novel variant SCCmec type in our MRSA 
population and were unable to assign SCCmec types with the Milheirico (2007) protocol on 
these isolates. Three representative isolates of both the novel and novel variant types were 
selected for further investigation using the Kondo (2007) protocol described below. One 
representative clinical isolate per control was also included, with the exception of SCCmec 
types I and VI, since none were identified in our sample population. 
3.2.2 Kondo mPCRs 1 - 5 
A collection of multiplex PCRs developed by Kondo et al. (2007) was performed to classify 
selected isolates into SCCmec subtypes. The reference strains used in these PCRs are shown 
in Table 3.1. 
Table 3.1 Reference strains (controls) used in the Kondo protocol 
SCCmec type Reference Strain mPCR Origin 
I BAA-38 1 - 3 ATCC 
II BAA-1681 1, 2, 4 - 6 ATCC 
IIb JCSC3063 4 PHRI Tuberculosis Center, Rutgers University
#
 
IIA BK351 4 PHRI Tuberculosis Center, Rutgers University 
IIE RN7170 4 PHRI Tuberculosis Center, Rutgers University 
III BAA-39 1 2, 4 - 6 ATCC 
IV BAA-1680 3 ATCC 
IVc 81/108 3 PHRI Tuberculosis Center, Rutgers University 
IVd JCSC4469 3 PHRI Tuberculosis Center, Rutgers University 
V WIS 1 - 2, 4 Medical Microbiology, UCT 
VI BAA-42 1 ATCC 
# Control strains from PHRO, New Jersey, kindly supplied by Prof Barry Kreiswirth 
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The reaction mixture of mPCR 1 contained 1 µL of crude DNA template, 0.1 µM of each primer 
(Integrated DNA Technologies, South Africa) (Table 3.2), 1X KAPA 2G Fast Multiplex Mix and 
nuclease free water to bring the final reaction volume up to 25 µL. The Veriti thermocycler 
(Thermo Fisher, USA) was used with an initial denaturation step at 94°C for 2 minutes, followed 
by 30 cycles of denaturation at 94°C for 2 minutes, annealing at 57°C for 1 minute and 
elongation at 72°C for 2 minutes. The final elongation step ran at 72°C for 2 minutes. Samples 
were held at 4°C until amplicons were visualized on 2% SeaKem LE Agarose as described in 
Chapter 2. 
The reaction mixture and cycling parameters of mPCRs 2 to 5 was identical to those used in 
mPCR 1, with the exception of the annealing step, which occurred at 60°C. PCR products for 
mPCRs 2 to 5 were visualized on 1.5 % SeaKem LE Agarose gels, as described in Chapter 2, 
Section 2.2.6. 
3.2.3 Kondo mPCR 6 
The last mPCR in the Kondo (2007) protocol amplifies the resistance-associated plasmids 
pT181 and pUB110 which are integrated into the J3 regions found in SCCmec types II and III 
and thus require a long range PCR protocol. We used 1x KAPA Long Range PCR Kit in 25 µL 
reaction volumes, including 0.3 µM of each primer (Table 3.2) and nuclease free water in a 
Touch-down PCR run. 
Cycling was initiated with a denaturation step at 94°C for 2 minutes, followed by 10 cycles of 
denaturation at 94°C for 15 seconds, annealing at 50°C for 30 seconds and elongation at 68°C 
for 8 minutes. The next 20 cycles had denaturation at 94°C for 15 seconds, annealing at 50°C 
for 30 seconds and elongation at 68°C for 12 minutes. The final elongation step ran at 72°C for 
7 minutes. Samples were held at 4°C until agarose gel electrophoresis and amplification 
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products were visualized on 1.5 % SeaKem LE Agarose gels with the KAPA Universal DNA 
Ladder (Appendix A), as described in Chapter 2, Section 2.2.6. 
Table 3.2 List of primers used for the Kondo (2007) protocol 






mA1 (F) TGCTATCCACCCTCAAACAGG 
mecA 286 
0.1 µM 
mA2 (R) AACGTTGTAACCACCCCAAGA 0.1 µM 
α1 (F) AACCTATATCATCAATCAGTACGT ccrA1-ccrB 695 0.1 µM 
α2 (F) TAAAGGCATCAATGCACAAACACT ccrA2-ccrB 937 0.1 µM 
α3 (F) AGCTCAAAAGCAAGCAATAGAAT ccrA3-ccrB 1791 0.1 µM 
ßc (R) ATTGCCTTGATAATAGCCITCT See above  0.1 µM 




ß 4.2 (R) TTGCGACTCTCTTGGCGTTT 0.1 µM 
Ɣ F CCTTTATAGACTGGATTATTCAAAATAT 
ccrC 518 
0.1 µM 
Ɣ R CGTCTATTACAAGATGTTAAGGATAAT 0.1 µM 
Kondo 2 
mI6 (R) CATAACTTCCCATTCTGCAGATG mecA-mecI 1963 0.1 µM 
IS7 (R) ATGCTTAATGATAGCATCCGAATG 
mecA-
IS1272 
2827 0.1 µM 
IS2(iS-2) (R) TGAGGTTATTCAGATATTTCGATGT mecA-IS431 804 0.1 µM 
mA7 (F) ATATACCAAACCCGACAACTACA See above  0.1 µM 
Kondo 3 
1a3 (F) TTTAGGAGGTAATCTCCTTGATG 
E007 154 
0.1 µM 
1a4 (R) TTTTGCGTTTGCATCTCTACC 0.1 µM 
4a1 (F) TTTGAATGCCCTCCATGAATAAAAT 
CQ02 458 
0.1 µM 
4a3 (R) AGAAAAGATAGAAGTTCGAAAGA 0.1 µM 
4b3 (F) AACCAACAGTGGTTACAGCTT 
M001 726 
0.1 µM 
4b4 (R) CGGATTTTAGACTCATCACCAT 0.1 µM 
4c4 (F) AGGAAATCGATGTCATTATAA 
CR008 259 
0.1 µM 
4c5 (R) ATCCATTTCTCAGGAGTTAG 0.1 µM 
4d3 (F) AATTCACCCGTACCTGAGAA 
CD002 1242 
0.1 µM 
4d4 (R) AGAATGTGGTTATAAGATAGCTA 0.1 µM 




Table 3.3 List of primers used for the Kondo (2007) protocol (continued) 
 kdpB1 (F) GATTACTTCAGAACCAGGTCAT 
kdpB 287 
0.1 µM 
 kdpB2 (R) TAAACTGTGTCACACGATCCAT 0.1 µM 
 2b3 (F) GCTCTAAAAGTTGGATATGCG 
SA01 1518 
0.1 µM 
 2b4 (R) TGGATTGAATCGACTAGAATCG 0.1 µM 





4b4 (R) CGGATTTTAGACTCATCACCAT 0.1 µM 
II4-3 (F) GTACCGCTGAATATTGATAGTGAT 
RN06 2003 
0.1 µM 
 II4-1 (R) ACTCTAATCCTAATCACCGAAC 0.1 µM 
 3a1 (F) ATGGCTTCAGCATCAATGAG 
Z004 503 
0.1 µM 
 3a2 (R) ATATCCTTCAAGCGCGTTTC 0.1 µM 
 5a1 (F) ACCTACAGCCATTGCATTATG 
V024 1159 
0.1 µM 
 5a2 (R) TGTATACATTTCGCCACTAGCT 0.1 µM 




2756 0.1 µM 




1540 0.1 µM 
 mN5 (R) TTGCTTCGGGACTTACCTCTAGT See above  0.1 µM 
 ant1 (R) CAGACCAATCAACATGGCACC 
mecA-
ant(4′) 
4952 0.3 µM 
Kondo 6 pT181-2 (R) AGGTTTATTGTCACTACAATTGA mecA-tetK 7406 0.3 µM 
 mA1 (F) TGCTATCCACCCTCAAACAGG See above  0.3 µM 
  




3.3.1 Kondo mPCR 1 
Kondo mPCR 1 typed the various ccr class combinations found in the SCCmec element (Figure 
3.1). 
 
Figure 3.1 Kondo mPCR 1. SCCmec types I to VI were used as controls. The novel and novel 
variant isolates and representative strains for each control were included. DNA markers 
(Ladders) and an NTC were also included. 
 
The novel type (Lanes 8 – 10) was shown to carry ccrC, which is characteristic of types V and 
VII. The novel variant (Lanes 11 – 13) had a combination of bands representing ccrC and 
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ccrA1B1. The isolates we included from our sample population (Lanes 14 – 17) all 
corresponded to their respective controls, with the exception of the type III isolate (Lane 15), 
which had a faint band matching ccrA2B2. The PCR was repeated and the same result was 
found, ruling out sample carry-over between wells during the loading of the gel, and possibly 
indicating that the isolate in question is a variant. 
3.3.2 Kondo mPCR 2 
Figure 3.2 shows the results of the mec class assignment that was done using Kondo mPCR 2.  
 
Figure 3.2 Kondo mPCR 2. SCCmec types I to V were used as controls. The novel and novel 
variant isolates and representative strains for each control were included. DNA markers 
(Ladders) and an NTC were also included. 
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Faint primer dimers can be seen at the bottom of the gel, however these do not impact on the 
results as they are very small and easily distinguishable from the rest of the products. The novel 
type isolates (Lanes 7 – 9) had class A mec genes and the novel variant type (Lanes 10 – 12) 
had class B mec genes. The clinical isolates (Lanes 13 – 16) correspond to their respective 
controls. The combined results of mPCRs 1 and 2 confirm the results of the Milheirico (2007) 
protocol: the novel variant resembles SCCmec type I, with the addition of ccrC (ccrA1B1C /class 
B mec) and the novel type has a previously unseen combination (ccrC /class A mec). 
3.3.3 Kondo mPCR 3 
This PCR inspected ORFs present in the J1 regions of SCCmec types I, IV, IVb, IVc and IVd 
(Figure 3.3). 




Figure 3.3 Kondo mPCR 3. SCCmec types I and three subtypes of IV were the control strains 
in this mPCR. The novel and novel variant isolates and representative strain for control IV were 
included. DNA markers (Ladders) and an NTC were alsoincluded. 
 
The control for type IVb could not be obtained for this study, however this is unlikely to impact 
on the results since the expected target (726 bp) was not observed in any of the isolates tested. 
Neither the novel nor the novel variant types (Lanes 6 – 11) had any amplification products, 
indicating that they do not share J1 region ORFs with types I or IV. The representative type IV 
isolate (Lane 12) from our population corresponds to subtype IVd. 
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3.3.4 Kondo mPCR 4 
Kondo mPCR4 targeted ORFs present in the J1 regions of SCCmec types II, IIb, IIA, IIE, III and 
V (Figure 3.4). 
 
Figure 3.4 Kondo mPCR 4. Four subtypes of SCCmec type II were used as controls in this 
mPCR, along with type III and V. A DNA marker (Ladder) and NTC were also included. 
 
Just as seen in mPCR3, the novel and novel variant types (Lanes 8 – 13) do not share any of 
the targeted J1 region ORFs with the SCCmec reference strains used. This correlates with 
results from the Milheirico (2007) protocol that show the novel type does not amplify the J1 
region target (Figure 2.5). The type III isolate from our population (TKB10, Lane 15) amplified 
the expected target (503 bp) as well as the type II target (287 bp). The PCR was repeated and 
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gel re-run to rule out carry-over between samples, with the same result. The representative 
SCCmec type V isolate from our population (Lane 16) and the control strain BAA-1688 (not 
shown) also had no amplification of the 1159 bp product associated with the type V J1 region. 
This supports the results from the Milheirico (2007) protocol that suggest it is a type V variant. 
3.3.5 Kondo mPCR 5 
Two transposons commonly associated with SCCmec types II and III, Tn554 and ΨTn554, were 
targeted in this mPCR (Figure 3.5).  
 
Figure 3.5 Kondo mPCR 5. SCCmec types II and III were the control strains in this mPCR. The 
novel and novel variant isolates and representative strains for each control were included. DNA 
markers (Ladders) and an NTC were also included. 
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The novel variant SCCmec type (Lanes 7 – 9) did not have any amplification, but the novel type 
(Lanes 4 – 6) was found to contain the 1540 bp product targeting ΨTn554, which is associated 
with cadmium resistance. The clinical isolates we included (Lanes 10 – 11) harbour the 
expected resistance-associated transposons related to their SCCmec types. 
3.3.6 Kondo mPCR 6 
Figure 3.6 shows the results of a long-range PCR which targeted resistance-associated 
plasmids found in the J3 regions of some SCCmec elements. 
 
Figure 3.6 Kondo mPCR 6. SCCmec types II and III were the control strains in this mPCR. The 
novel and novel variant isolates and representative strains for each control were incuded. DNA 
markers (Ladders) and an NTC were also included. 
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pUB110 (4952 bp), which confers resistance to bleomycin and tobramycin, was not present in 
the novel or novel variant types (Lanes 4 – 9). pT181 (associated with tetracycline resistance, 
7406 bp) was found in the novel type (Lanes 4 -6). The clinical isolates representing type II 
(Lane 10) amplified a target that appears slightly larger than the control, however since the 
products are so large, it is likely that this is due to uneven DNA separation across the gel. 
Amplification for pT181 in the type III isolate (Lane 11) was extremely faint, possibly indicating 
either a very low copy level of the plasmid or the absence of the plasmid. A second band could 
also be observed for this isolate, but it is unclear whether this is true amplification or non-
specific bands. The absence of this plasmid may indicate that this isolate is a type IIIA variant. 
  




3.4.1 Characterization of the novel SCCmec type 
The combination of the Milheirico (2007) and Kondo (2007) protocol results show that the 
putative novel SCCmec type found in our MRSA isolates contains an unpublished ccr complex-
mec complex combination. The ccr class found in this type is characteristic of types V, VII and 
the SCCHg element (Ito et al. 2004; Chongtrakool et al. 2006; Berglund et al. 2008), and the mec 
class of types II, III and VIII (Ito et al. 2001; Zhang et al. 2009). It is improbable that the novel 
element was formed via any recombination event including types V, VII and VIII, since only one 
type V isolate was identified in our setting, and type VII and VIII were not present. It is therefore 
expected that the ccrC class seen in the novel type originated from a SCCHg element. The 
SCCmec III isolates in our population also amplified ccrC, indicating that they possibly carried 
the SCCHg element. The combination of type III and SCCHg is frequently reported (Chongtrakool 
et al. 2006). However, the type III isolate from our population did not amplify the target for 
Tn554 which is present in SCCHg but rather showed faint amplification of regions corresponding 
to type II. To our knowledge, the combination of ccr types 2 and 3 (ccrA2ccrB2, ccrA3ccrB3) 
has been reported in MR-CoNS specimens, but not in MRSA (Sani et al. 2014). Further 
genomic analysis is required to determine the true structure of these SCC elements. 
Furthermore, our results show that the novel type contained a resistance-associated transposon 
and a resistance-associated plasmid, both associated with SCCmec type III. Interestingly, many 
of the novel type isolates were grouped in the same PFGE pulsotypes as the type III isolates, 
indicating further genotypic similarity between the two types (Karayem 2014). There was no 
amplification in any of the J1 region targets in the novel type, indicating a possible deletion or 
sequence change in the J1 region.  
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3.4.2 Characterization of the novel variant SCCmec type 
The novel variant SCCmec type found in our MRSA population had a similar banding pattern to 
SCCmec type I using the Milheirico (2007) protocol and this was confirmed using the first two 
multiplex PCRs of the Kondo (2007) protocol. This variant carried a combination of a class B 
mec and ccrA1B1 as well as the same ccrC class found in the novel type. No other amplification 
products were found in any of the joining regions; therefore it is unclear if the novel variant 
shares similarity with other SCCmec types in our setting. The addition of ccrC to this element 
may be an indication that it has also acquired SCCHg, just as seen with the novel SCC element; 
but typing showed that a characteristic transposon carried by SCCHg, Tn554, was not present. 
This suggests that the SCCHg element may be truncated, or that ccrC was acquired by 
recombination with the other SCCmec elements in our setting that carry it. The fact that the 
novel, novel variant and SCCmec III elements in our population contain ccrC may indicate that 
it, or the element it is likely carried on, is easily transferred between SCCmec types or that it 
conveys a fitness advantage to MRSA isolates in a clinical setting.  
3.4.3 Conclusion 
The Kondo (2007) protocol confirmed the results of SCCmec typing with the Milheirico (2007) 
protocol and showed that our MRSA population contained isolates with unique SCCmec 
elements. Novel combinations of the main gene complexes, ccr and mec were identified in our 
novel and novel variant SCCmec types. Furthermore, the Kondo (2007) protocol allowed us to 
detect the presence or absence of other important resistance determining elements in these 
novel types. The J1 regions in both the novel and novel variants need to be inspected further to 
determine whether there has been a deletion or if it has been changed in such a manner that 
the PCR primers cannot detect it. The Kondo (2007) protocol provides the best discriminatory 
power of the SCCmec typing assays and is the typing method recommended by the IWG-SCC 
(http://www.staphylococcus.net). However, while it provides a great deal of insight into the 
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composition of novel SCC elements, sequencing the entire length of these elements is essential 
in order to elucidate and confirm their structure (Ito et al. 2009). 
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Chapter 4: Whole Genome Sequencing 
4.1. Introduction 
The rapidly growing diversity of SCCmec types, especially those present in MR-CoNS isolates, 
presents significant challenges for conventional SCCmec typing assays such as mPCR. The 
reason is that changes in genetic structure, such as insertions and deletions (indels) and single 
nucleotide polymorphisms (SNPs) may influence the ability of these mPCRs to effectively target 
and amplify important regions. While most SCCmec typing assays can assist in identifying 
possible novel types, sequencing of the elements is necessary to fully characterize their 
structures. 
Recent advances in next-generation sequencing (NGS) and increased availability of NGS 
technology have made it an ideal tool for genotypic analysis. NGS generates large amounts of 
data that can be assembled de novo to detect novel regions and aligned against closely related 
reference sequences to detect SNPs and indels. 
We submitted a selection of isolates for whole genome sequencing using NGS Illumina 
technology, to characterize the structures of the putative novel and novel variant SCC elements 
identified in our setting. 
  




4.2.1. Sample selection 
We selected 11 MRSA isolates and one MR-CoNS (S. epidermidis) isolate for whole genome 
sequencing, based on their SCCmec typing results with the Milheirico (2007) and Kondo (2007) 
protocols. We also considered results from other epidemiological tests such as PFGE, spa 
typing and MLST (as determined previously by Karayem et al., 2014). It was noted that all of the 
novel SCCmec type isolates clustered in pulsotypes that also contained SCCmec type III 
isolates and that these isolates (with both the novel element and SCCmec III) shared the same 
spa type, t037 and sequence type (ST), ST239. Therefore five SCCmec type III isolates were 
selected for WGS analysis, to compare the structure of the SCCmec type III elements to those 
found in the novel type (Table 4.1). 
Table 4.1 Representative samples chosen for WGS 
Sample Name Sequencing Name SCCmec type 
TKB-8 M8 Novel variant 
TKB-16 M16 Novel variant 
TKB-10 M10 Novel 
TKB-11 M11 III 
TKB-14 M14 Novel 
TKB-108 M108 III 
TKB-105 M105 Novel 
TKB-106 M106 III 
TKB-77 M77 Novel 
TKB-156A M156A III 
TKB-156B M156B III 
Co8 (CoNS) MCo8 Novel 
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4.2.2. DNA extraction 
Commercial DNA extraction kits failed to produce sufficient quantities of quality DNA, therefore 
an in-house phenol-chloroform DNA extraction optimized for Mycobacterium tuberculosis 
(Warren 2016) was adapted and used to extract DNA from the staphylococcal isolates. All 
media and buffer compositions are listed in Addendum A. Briefly; blood agar plates (NHLS 
Media Laboratory) were inoculated with a single microbank bead and incubated at 37°C for 18 – 
24 hours. A loopful of colonies was suspended in sterile saline solution and used to culture a full 
lawn of growth on two tryptic soy broth (TSB) agar plates (Addendum A) per isolate at 37°C for 
24 hours. 
50 ml polypropylene tubes (Falcon tubes) were prepared with 12mL of DNA extraction buffer 
(pH 7.4) (Addendum A) and approximately 20x 5mm glass balls. Sterile loops were used to 
scrape off and transfer the culture to the Falcon tubes in a class II laminar flow cabinet. The 
Falcon tubes were then vortexed until the mixtures were homogenized and no clumps were 
observed. 60 µL of a cell lysis agent, lysostaphin (10 mg/mL) (Sigma-Aldrich, South Africa), was 
added to each tube and then mixed by gentle inversion and incubated at 37°C for 30 minutes. 
600 µL of 10X proteinase K buffer (pH 7.8) (Addendum A) and 300 µL of proteinase K (10 
mg/ml) (Qiagen, Germany) were added to each tube, gently mixed by inversion and incubated 
overnight at 42°C. Proteinase K inactivates any nucleases released during cell lysis that may 
degrade the DNA in the buffer. 
10 mL of phenol/chloroform/isoamyl alcohol (25:24:1) was added to the Falcon tube in a fume 
hood, and gently mixed by inversion every 30 minutes for 2 hours. This was done to separate 
the samples into phases, based on their solubility in water. The tubes were then centrifuged at 
3000 x g for 20 minutes after which the top aqueous phase containing the DNA was carefully 
removed and placed in a sterile Falcon tube. The phenol/chloroform/isoamyl alcohol step and 
centrifugation was repeated, without the 2 hour incubation, to ensure clean separation of the 
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DNA from other viscous cell materials. The top aqueous phase was aspirated into a tube 
containing 10 mL chloroform/isoamyl alcohol (24:1), mixed gently and centrifuged at 3000 x g 
for 20 minutes. This step removes any traces of phenol and minimizes the negative effects it 
might have on downstream WGS analysis. The top phase was again carefully aspirated into 
sterile Falcon tubes containing one tenth volume 3M sodium acetate (pH 5.2) (Sigma-Aldrich, 
South Africa) to change the charge and pH of the DNA, thereby making it more hydrophobic and 
easier to precipitate. 
One volume of ice cold 100% isopropanol was added slowly with minimal movement to avoid 
premature precipitation which leads to the presence of unwanted compounds. The Falcon tubes 
were inverted slowly three to four times to precipitate the DNA, which was immediately fished 
out of the solution using sterile glass rod hooks. These rods with the DNA were placed in 
microcentrifuge tubes containing 1 mL 70% ethanol and incubated at room temperature (25°C) 
for 10 minutes to remove excess salts. The rods were then transferred to sterile 1.5 mL 
microcentrifuge tubes and incubated at room temperature until all the ethanol had evaporated. 
Once dry, the DNA was rehydrated in TE (Tris-EDTA) buffer (pH 8.0) (Addendum A) and 
released from the rods by gentle mixing and placed in an incubator at 65°C for one hour. The 
EDTA in this buffer chelates metal cations in the sample and effectively inactivates any DNA-
degrading nucleases still present. The amount of TE buffer added to each sample varied from 
300 to 600 µL, depending on the amount of DNA extracted and the viscosity of the sample. 
The DNA concentration was measured spectrophotometrically with a BioDrop µLite (Whitehead 
Scientific, Cape Town) to assess A280/260 and A260/230 ratios. Additional TE buffer was 
added to particularly viscous samples that were difficult to pipette. The A280/260 ratio for pure 
DNA is expected to fall between 1.8 and 2.0 and values lower than this may be an indication of 
contaminants that absorb at 260 nm, such as phenol. The A260/230 values are expected to 
range between 2.0 to 2.2 and lower values may indicate the presence of contaminants that 
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interfere with sequencing. However, values as low as 1.5 have been found to be adequate for 
sequencing. 
4.2.3. Quality Control of extracted DNA 
To ensure sufficient quantities and quality of starting material, various quality control tests were 
conducted by the Centre for Proteomic and Genomic Research (CPGR) prior to sequence 
library preparation. The DNA concentration of each sample was spectrophotometrically 
measured for a second time with the Nanodrop ND 1000 (Thermo Scientific, USA). 
To determine the absolute dsDNA concentration, fluorometric measurement was done with the 
Qubit dsDNA BR assay on a Qubit 2.0 fluorometer. The integrity of the genomic DNA was 
evaluated by 2% gel electrophoresis to look for high molecular weight DNA (larger than 10 kb). 
4.2.4. DNA library preparation and cluster amplification 
The Nextera® XT DNA Sample Preparation Kit (Illumina, South Africa) was used to create 
libraries for sequencing, following the manufacturer’s protocol (Addendum B). Briefly, input DNA 
was simultaneously fragmented and tagged (tagmented) with end-adapter sequences by the 
Nextera XT transposome. Tagmented DNA was then amplified by a multiplex PCR which added 
unique adapters and other sequences required for cluster formation. Following amplification, the 
samples were barcoded with unique combinations of indices to allow sample pooling during 
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M11 M10 M77 M156A 
S508 
CTAAGCCT 
M156B M14 M108 M16 
S517 
GCGTAAGA 
M8 M105 M106 MCo8 
 
Finally, the library DNA was purified with AMPure XP beads (Beckmann Coulter), to remove 
very short library fragments, thereby improving the quality of subsequent sequencing reactions. 
Equal volumes of normalized library were combined and diluted in hybridization buffer, and heat 
denatured. The libraries were then loaded onto the MiSeq Reagent Kit v3 (Illumina) cartridges 
following the manufacturer’s instructions. 
4.2.5. MiSeq Illumina sequencing 
The clonal clusters used for sequencing were generated via bridge amplification (Figure 4.1).  




Figure 4.1 Formation of clonal clusters for Illumina sequencing (http://www.illumina.com) 
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The MiSeq sequencer used Illumina’s sequencing by synthesis (SBS) technology to sequence 
the clusters (Figure 4.2).  
 
Figure 4.2 Sequencing by synthesis technology used by the MiSeq sequencer. Bases are 
sequentially washed over the flow cell, and only one matching nucleotide can be incorporated at 
a time depending on the sequence of the strand. When this happens, a fluorescent signal is 
emitted and captured by the sequencer. (http://www.illumina.com) 
 
The fluorescence generated by fluorophore labeled reversible terminators was measured. 
These terminating dNTPs block polymerization, causing only a single base to be incorporated at 
a time and therefore allowing accurate base-by-base sequencing results. Every cluster is 
imaged simultaneously, thereby generating massively parallel sequencing data. After imaging, 
the terminators were cleaved to allow incorporation of the following base.  
After the forward strands were sequenced, the reverse strands were reformed by a single bridge 
amplification step, followed by clipping of the forward strands. The sequencing process was 
then repeated for the reverse strand. Since each sample was barcoded with unique indices, the 
resulting forward and reverse reads of each sample can be identified and paired together for 
downstream analysis. 
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4.2.6. Sequence quality analysis 
For the 600 cycle MiSeq reagent kit v3, sequencing data output is expected to be as high as 15 
Gb with 70% or more of the data passing a quality (Phred) score of 30 (Q30). Q scores are 
logarithmically related to base call error probability, for example Q30 is equivalent to 1 incorrect 
base call per 1000 bases (99.9% accuracy) and Q20 is equivalent to 1 error per 100 bases 
(99% accuracy rate). Low Q scores will result in false-positive variant calls in downstream 
analysis, which makes data untrustworthy. The gold standard for read quality in next-generation 
sequencing analysis is Q30, and reads below this value should preferably be filtered out during 
analysis. In addition to the quality score summary provided with the data, each sequence file 
was also subjected to an individual and comprehensive quality control (QC) check using 
FastQC version 0.10.1 (Babraham Bioinformatics, UK). FastQC provided information about the 
sequence quality, sequence content, GC content, sequence length distribution and sequence 
duplication levels for each individual sequence file. 
4.2.7. Genome assembly and annotation 
Figure 4.3 summarizes the genome assembly and annotation pipeline that was used. 




Figure 4.3 Genome assembly and annotation pipeline used for this study 
 
De novo genome assembly was performed using the St. Petersburg genome assembler 
(SPAdes v3.6.0, Algorithmic Biology Lab) (Bankevich et al. 2012) through the online service at 
BaseSpace (Illumina, USA). Samples that contained more than 1.00 gigabases of data (SPAdes 
online application limit) were run with SPAdes on a command line basis. Parameter 
specifications for the command line tools used in this pipeline can be found in Addendum B: 
Supplementary Methods. 
Stellenbosch University  https://scholar.sun.ac.za
69 
 
The SPAdes assembler produced contigs (contiguous DNA sequences of overlapping reads) in 
fasta format, ready for downstream analysis. The quality of the assembly was assessed using 
QUAST (Gurevich et al. 2013) to produce statistics including GC content (%), the total length of 
the assembly, the number of contigs and the N50 value, which are important markers for 
assembly quality. There are no quality cut-offs for these values, however it is generally accepted 
that fewer contigs (<200) and high N50 values (>10000) are indications of good assemblies. 
The N50 value indicates that 50% of the contigs in the assembly are the size (in bp) of the N50 
value or larger, therefore a high N50 value indicates that most of the contigs are large and that 
assembly was efficient. The QUAST quality report was automatically generated using the online 
SPAdes application and manually generated through a web-based utility 
(http://quast.bioinf.spbau.ru/) for the command line SPAdes assemblies. 
The contigs generated by SPAdes were ordered against closely related reference sequences 
from the NCBI online repository. JKD6008 (accession NC_017341) contained a SCCmec type 
III region and was therefore used as reference for the novel and type III isolates. COL 
(accession NC_002951) contained a SCCmec type I region and was used as reference for the 
novel variant isolates. A methicillin resistant S. epidermidis (MRSE) genome, ATCC 12228 
(accession NC_004461) was chosen as reference for the S. epidermidis isolate, since it has 
been used as an MRSE reference genome in a South African setting before (Biswas et al. 
2015). The expected genome sizes for the MRSA isolates was between 2.8 and 2.9 Gb and the 
MRSE isolate was expected to have a genome of 2.4 to 2.5 Gb. The alignment was done using 
the “Move Contigs” function of the progressive Mauve multiple genome alignment tool (Darling 
lab, Sydney) (Darling et al. 2010). A comparison between the reference sequence and the 
newly ordered contigs was generated using command line tools. The alignment was then 
visualized with the Artemis Comparison Tool (ACT, Wellcome Trust Sanger Institute, UK) 
(Carver et al. 2005) to inspect synteny and homology between the genomes. 
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We transferred the annotation from our reference sequences to our ordered contigs using the 
Rapid Annotation Transfer Tool (RATT) (Otto et al. 2011). Areas without synteny, i.e. those 
unique to the ordered contigs, were annotated manually with BLAST searches through the 
Artemis DNA viewer and annotation tool (Rutherford et al. 2000). We also annotated a subset of 
isolates automatically with Rapid Annotation using Subsystem Technology (RAST) v2.0 (Aziz et 
al. 2008) at http://rast.nmpdr.org/rast.cgi to confirm the annotation done via RATT and manually.  
  




4.3.1. DNA extraction 
The extracted DNA was noted to be very viscous in all twelve samples, due to the high 
concentration of DNA present. Samples that were difficult to work with were diluted with 
additional TE buffer before spectrophotometric analysis. Spectrophotometers (including the 
BioDrop µLite) are known to overestimate the amount of DNA; therefore, our samples were 
diluted to 100 ng/µL in 100 µL of TE buffer to ensure that sufficient DNA concentrations (30 
ng/µL) were provided for whole genome sequencing. 
4.3.2. Quality Control of extracted DNA 
All samples passed QC and showed no significant deviations. The A280/260 ratios of all 
samples ranged between 1.86 and 2.05, indicating high purity DNA and the A260/230 values 
were between 1.73 and 3.01. Qubit analysis provided accurate DNA concentration 
measurements, ranging between 30.9 and 59.9 ng/µL, with the exception of a single sample 
that had an unusually high concentration (620 ng/uL). This sample was noted to be extremely 
viscous, and it is likely that the viscosity affected the accuracy of the initial BioDrop reading. All 
twelve samples had intact genomic DNA (gDNA) and only contained minor single stranded DNA 
(ssDNA) and RNA contaminants which do not interfere with the library preparation assay 
(Addendum A). 
4.3.3. Sequence quality analysis 
The total sequencing data output was 11.41 Gb with 68.3% of all sequences at or exceeding 
Q30 scores (Figure 4.4). 




Figure 4.4 Quality scores (Q) across all reads 
 
FastQC analysis showed that the sequence read lengths ranged between 35 and 301 bp. The 
average quality score per read was between 34 and 36 and the GC content ranged between 32 
and 35%. No overrepresented sequences were found. The analysis indicated some sequence 
duplication in all of the samples; however this is most likely a false overrepresentation due to 
the long read length and high coverage of the sequences. The per base sequence content 
(representation of A, T, G or C) showed a deviation from normal distribution in the first nine 
bases of the reads; however, this is a known bias characteristic of Illumina sequencing and 
does not influence downstream analysis. The data were of sufficient quality to continue with 
sequence analysis. 
4.3.4. Genome assembly and annotation 
All but three isolates were assembled with the online SPAdes application through BaseSpace. 
The remaining three isolates consisted of more than 1.0 gigabases of data and were run with 
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SPAdes using command line options. Figure 4.5 below shows a QUAST quality report of one of 
the assemblies (TKB-106); and average quality results for selected statistics for all assemblies 
are shown in Table 4.3. 
 
Figure 4.5 QUAST quality report (sample TKB-106). All statistics are based on contigs >500 
bp, unless stated otherwise. 
 
Table 4.3 Assembly statistics for all isolates 
Assembly Statistic Range (Min – Max) Average 
# contigs (≥1000 bp) 23 - 88 60 
# contigs (≥500 bp) 44 - 113 81 
GC (%) 32,12 – 32,9 32,68 
N50 77590 - 243965 134350 
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As seen in Figure 4.5 and Table 4.3, the N50 values of all samples was >77500 and this 
indicates that the assemblies should have good quality. The number of contigs (≥500 bp) for the 
selected S. aureus isolates were between 44 - 113. The S. epidermidis isolate was expected to 
have a smaller genome than the S. aureus isolates and therefore had less than the average 
number of contigs ≥500 bp (64). The total length of each assembly was larger than the actual 
genome sequence, as many of the smaller contigs may have been misassemblies or regions 
already contained within larger assembled contigs. Mapping the assembly to a closely related 
reference helps to filter out these contigs, as a large percentage of them will remain unmapped 
and appear at the end of the alignment. This was visualized using ACT as shown in Figure 4.6. 




Figure 4.6 Visual comparison of a reference sequence (JKD 6008, top) and ordered contigs (TKB-105, bottom). Red blocks 
show similarity/synteny between the genomes, blue blocks show areas of synteny that have an inversed configuration in the query 
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The ACT comparison (Figure 4.6) showed that the two genomes we aligned were highly similar, 
with isolated areas with unique sequences. The reference and query sequences can be found 
above and below the comparison panel respectively, with set intervals (in this case 175000 bp) 
marking the length of the genomes. For each genome, four rows extend from both the forward 
(top) and reverse strand (bottom), showing the relative position of all annotated features on the 
genome (row 1), as well as their position on either the first, second or third amino acid reading 
frame (rows 2 - 4). Two graphs were also included, showing the typical GC skew/deviation 
across the S. aureus reference genome and the query genome. Unmapped contigs, and those 
that mapped, but did not align well, were shown at the end of the query alignment (bottom). The 
GC skew for many of these unmapped contigs was extremely high, indicating that these regions 
may have a high copy number (e.g. repeat regions); and this may also explain why their 
alignment was unsuccessful. These contigs can be moved and ordered manually, however this 
requires advanced editing skills and is extremely laborious and time-consuming. The SCCmec 
region is found close to the origin of replication, and the alignment for this region is shown in 
Figure 4.7. 




Figure 4.7 Alignment of the SCCmec regions of the reference (JKD6008, top) and query 
(TKB-105, bottom). The arrows below the figure indicate regions unique to the query, where no 
annotation was transferred. 
 
As seen in Figure 4.7, annotation of large sections of this region was unsuccessful, as those 
elements in the query were not present in the reference, or were significantly different, and 
could therefore not be transferred. These regions were inspected in the Artemis DNA viewer 
and possible ORFs were marked, submitted for BLAST nucleotide searches and manually 
annotated.  
4.3.5. Novel SCC element structure 
We used the assembly and annotation results to construct the proposed novel SCC element 
found in our setting in Figure 4.8. 




Figure 4.8 Structural comparison between a reference SCCmec type III and two SCC 
types found in our study. A: SCCHg and SCCmec III (commonly carried together). B: 
SCCmec IIIA. C: Novel SCC element (designated ΨSCC). 
 
Our analysis showed that all of the SCCmec type III isolates that were submitted for sequencing 
carried SCCmec IIIA elements. Type IIIA elements have mec Class A in combination with 
ccrA3ccrB3 (ccr Type 3). The lack of the pT181 tetracycline plasmid seen in our isolates is 
characteristic of SCCmec IIIA. ORFs typical of SCCHg were found between the J3 region and 
orfX, including ccrC. However, this region lacked the characteristic Tn554 (erythromycin 
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The novel SCC element was shown to carry the same mec complex as SCCmec type III (mec 
Class A), as well as some ORFs in the J2 region, namely the ΨTn554 region encoding for 
cadmium resistance. However, the element appeared to be truncated after the J2 region, 
downstream from ΨTn554, and was missing a functional ccr complex, as well as the majority of 
the J1 region. The truncated SCC-like element (designated ΨSCC) was found together with a 
SCCHg-like element that lacked Tn554, but carried the ccrC and mer regions. The novel element 
also contained pT181, which is characteristic of SCCmec III, but not IIIA. 
We were unable to visualize the structure of the novel element that we had postulated in our 
CoNS isolate, due to the lack of suitable reference strains carrying the appropriate SCC 
elements. However, we were able to identify key features and genes present in its genome. 
orfX, ccrC and mec Class A were all present and similar to those found in the novel SCCmec 
elements in S. aureus. With the exception of the tetracycline resistance plasmid, pT181, we 
found no other SCC-like resistance plasmids or transposons (Tn554 and ΨTn554) seen in the 
novel and IIIA SCC elements. A functional ccr complex type 4 (ccrA4ccrB4) was also present in 
this isolate. 
4.3.6. Novel variant SCC element structure 
When compared to SCCmec type I, the novel variant SCC element found in our study carried 
the same ccr type (ccrA1ccrB1) and the same mec (Class B) (Figure 4.9). The two insertion 
sequences, IS341 and IS1272 were found in the same direction and position relative to 
SCCmec type I. In addition to the SCCmec I regions, an additional SCCHg-like element was 
inserted between the J3 region and orfX. It is similar to the ones seen in our novel and SCCmec 
IIIA elements, but has a unique region showing 64% similarity to a putative staphylococcal 
superfamily II DNA/RNA helicase. No other resistance encoding transposons or plasmids were 
found. 




Figure 4.9 Structural comparison between a reference SCCmec type I and a novel variant 









4.4.1. Characterization of the novel SCC element 
We subjected a set of isolates representing the type III and novel SCCmec elements found in 
our study to whole genome sequence analysis in an attempt to confirm and clarify the results 
found with the SCCmec typing assays. Sequencing analysis confirmed that the isolates 
identified (by mPCR) as carrying SCCmec type III were indeed the variant IIIA (Chongtrakool et 
al. 2006) that lacked the pT181 plasmid. SCCmec typing showed that our type IIIA isolates also 
carried ccrC, indicating that they were possibly harbouring the SCCHg element; which is 
commonly carried together with SCCmec III (Ito et al. 2009). However, further typing failed to 
amplify any other SCCHg resistance elements. Whole genome sequencing showed that these 
isolates were carrying a truncated, SCCHg-like element harbouring ccrC, which integrated 
between orfX and the type IIIA J3 region. A truncated SCCHg element, Tn6072, has been 
described in the literature; however it only lacks the mer operon, whereas the one we described 
here lacks both mer and Tn554 (Chen et al. 2010). 
Assembly of the novel SCCmec element confirmed the lack of type III ccr genes and J1 ORFs 
seen in the Milheirico (2007) and Kondo (2007) mPCRs; and showed a deletion of the ccr gene 
complex and the majority of the J1 region. A SCCHg-like element was also integrated between 
the J3 region and orfX. Although the novel element showed many similarities to our IIIA isolates, 
it also carried the pT181, encoding tetracycline resistance, found in SCCmec type III. The 
SCCHg-like element carried with the novel element was also different; as it contained the mer 
operon which was absent in the IIIA isolates. The novel element did not appear to carry a 
functional ccr complex, and would therefore be considered a ΨSCC element on its own. 
However, it is possible that the SCCHg-like element (carrying ccrC) has fused with the SCC 
element in a similar way as seen in SCCmec type VII (Berglund et al. 2008), thereby generating 
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a novel arrangement of the ccr and mec complexes. Further analysis is required to determine 
whether these elements have fused, or if they are a composite of two distinct SCC elements. 
Although the initial SCCmec typing assays showed that the novel element in the MRSA isolates 
appeared similar to the SCC element in the CoNS isolate, genomic analysis showed a few key 
differences between the two. Unlike the novel SCC element in the MRSA isolates, the CoNS 
isolate did not carry the ΨTn554 or mer resistance regions. It was also shown to harbour a 
functional ccr complex (ccrA4ccrB4) which has previously been found in SCC-CI elements 
carried by S. epidermidis strains (Ito et al. 2009). These discrepancies in the SCC regions, as 
shown by genomic analysis, highlight the shortfalls of traditional SCCmec typing assays and 
show the importance of genome sequencing to assign SCCmec types accurately. Sequencing 
has the greatest discriminatory power for typing and is the gold standard for these assays. Even 
so, the cost of genomic analysis is too high for frequent use in resource limited settings and 
therefore SCCmec typing by mPCR still remains the suggested assay for epidemiological 
research (IWG-SCC 2016). 
4.4.2. Characterization of the novel variant SCC element 
As seen in the type IIIA and novel SCC elements, the novel variant SCC element also carried 
ccrC on a truncated SCCHg-like element. The SCCmec region of these isolates was almost 
identical to SCCmec type I and shared all of its main gene complex arrangements and ORFs. 
While the combination of SCCHg and SCCmec III is abundant, this is the first report to our 
knowledge of an SCCHg-like element carried together with a SCCmec type I element. 
The main difference between the SCCHg-like element and the others found in our study is the 
presence of an ORF between ccrC and the SCCmec element, encoding a putative helicase. 
Helicases separate double stranded DNA into single strands and are essential for DNA 
replication. A BLAST search showed that this ORF only shared 64% similarity to its closest 
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match in an S. epidermidis genome and it may therefore represent a novel type helicase. It is 
not uncommon to find genes associated with replication in SCC elements and it has recently 
been suggested that these genes allow the SCC elements to replicate independently once they 
are excised from a genome, thereby increasing the efficiency of HGT (Mir-Sanchis et al. 2016).  
4.4.3. Dissemination of the novel SCC and SCCHg-like elements in our setting 
Our results show that truncated SCCHg-like elements were widely disseminated in our setting 
and were found in the majority of our isolates, including the novel, novel variant and SCCmec 
IIIA isolates. It has been suggested that the spread of smaller or truncated elements may confer 
a fitness advantage to the population; however further research needs to be done to assess 
fitness benefits (Boyle-Vavra & Daum 2007; Chen et al. 2010). A second unconfirmed 
explanation may be that smaller elements such as the ones seen in our setting are much easier 
to excise and integrate into genomes, and therefore spread more easily than the larger 
elements. 
Although we did not find the novel SCC element in our CoNS population, research has 
suggested that the SCCHg element originated from CoNS and was transferred to S. aureus 
(Chongtrakool et al. 2006). While there is a need to compare the differences and similarities of 
SCC elements between S. aureus and CoNS isolates; working with CoNS genomic data 
presents significant difficulties. The lack of reference sequences and standardization of 
SCCmec types in CoNS and the sheer genetic diversity and variety of species in this group are 
major obstacles in this field of research (Zong et al. 2011). This held true in our own setting 
where we were able to identify the presence of individual elements, but unable to fully construct 
the novel SCC region in our sequenced CoNS isolate, even when aligned to a suitable 
reference. In order to construct the entire element, primers will need to be designed for targeted 
sequencing of long range PCR products spanning the length of the element. 




Preliminary genomic analysis showed that the presence of ccrC in our novel and novel variant 
SCC elements was conveyed by structures similar to SCCHg. In both cases the SCCHg-like 
element was truncated and did not carry all of the genes it is traditionally associated with. The 
novel SCC element did not appear to carry a functional ccr complex, but it is possible that there 
was integration between it and the SCCHg-like element. Further analysis is therefore necessary 
to confirm whether the novel and novel variant SCC elements found in our setting are 
composites of multiple SCC elements, or if the rearrangements in structure constitute novel 
SCCmec types. The International Working Group on the Classification of Staphylococcal 
Cassette Chromosome Elements (IWG-SCC) will be contacted to assist in the classification of 
these elements. 
The dissemination of the novel SCC element among local MRSA isolates may reflect clonal 
spread within the hospital. The finding of a similar novel element within a MR-CoNS isolate 
suggests CoNS as a potential source, however further phylogenetic analysis is required to 
provide insights into how these novel elements emerged. 
During this study, we produced large amounts of genomic data that will be vital for future 
research. In-depth analysis of the SCC and other resistance regions will provide insights into the 
characteristics of our MRSA population. Phylogenetic analysis using WGS data provides the 
highest level of discrimination and will accurately show the relationship of our local MRSA 
isolates with global strains. The genome drafts will be submitted to the NCBI database once 
they have been fully curated and annotated. 
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Chapter 5: Conclusion 
Methicillin resistance in staphylococcal species, both S. aureus and CoNS, can be largely 
attributed to the acquisition of the large mobile genetic element (MGE), SCCmec. SCCmec 
elements consist of two major gene complexes, mec and ccr and various other resistance 
determining factors. Many non-mec SCC elements have also been discovered and are common 
in MR-CoNS isolates. 
In this study, we aimed to describe the epidemiology of SCCmec types present in MRSA and 
MR-CoNS isolates from Tygerberg Hospital. We utilized a mPCR-based SCCmec typing assay 
developed by Milheirico et al. (2007) to determine the prevalence of the major healthcare 
associated SCCmec types in the MRSA and MR-CoNS populations. Typing showed that the 
majority of the MRSA population belonged to either a putative novel SCCmec type or a novel 
variant SCCmec type; however only one novel type was identified in the MR-CoNS group. 
Furthermore, the MR-CoNS population consisted of a large percentage of SCCmec IV, but the 
majority were not typeable by conventional SCCmec typing schemes. The lack of the novel 
element in the MR-CoNS population could be an indication that it conveyed no evolutionary 
advantage to the population. While it is unlikely, differences in collection time of the two 
populations may have influenced the results and may therefore be useful to screen the current 
MRSA population, to confirm that the novel and novel variant SCCmec elements are still 
present. 
We investigated the novel and novel variant SCC elements in more detail, by performing a 
comprehensive typing assay described by Kondo et al. (2007) on a subset of representative 
isolates. This protocol confirmed the results from the Milheirico (2007) protocol, but also 
provided a more descriptive picture of additional resistance determinants present in the novel 
and novel variant SCC elements. The novel, novel variant and representative isolates from 
SCCmec type III were shown to carry ccrC, a gene commonly found on an SCC element known 
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as SCCHg. In contrast, none of these isolates showed amplification for a resistance determining 
transposon, Tn554, which is carried on SCCHg. While PCR-based SCCmec typing can 
determine the presence or absence of multiple genetic targets, a major drawback is that their 
position and relative orientation to one another is not revealed. To combat this, novel SCCmec 
types need to be characterized by sequencing the entire length of the element. 
We selected representative isolates from our study population for whole genome sequencing 
using the NGS Illumina platform. Using this data, we constructed the SCCmec elements of the 
novel, novel variant and SCCmec type III isolates and compared the structures to those of 
closely related reference strains. The novel variant was shown to be a possible composite of 
two SCC elements, SCCmec I and a truncated SCCHg element. Our type III isolates were shown 
to be IIIA variants that do not carry pT181 resistance determining plasmids, but a truncated 
SCCHg element could also be found between the 5’ end of the element and the SCCmec IIIA 
mec complex. The novel element was very similar to SCCmec type III, but it was shown be 
truncated and did not contain a functional ccr complex. A SCCHg-like element encoding a 
mercury resistance operon was present between orfX and the pT181 plasmid. It is possible that 
some of the composite elements found in this study have integrated with their respective SCC 
elements and are effectively carried together. If this is truly the case, it may constitute a novel 
SCCmec element; however further research is necessary to investigate whether integration has 
taken place. 
Future directions 
The novel and novel variant SCC structures described in this study need to be confirmed using 
in-depth genome analysis. This may include the use of PCRs designed to confirm the presence 
and position of key integration sequences in and around the elements and to define the start 
and end of the elements. This will enable us to determine whether the novel and novel variants 
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are composites of two elements, or if integration has taken place and constitute novel SCCmec 
types. We will consult with the IWG-SCC on the naming and classification of these elements. 
The whole genome sequencing data is a great store of information and has multiple uses for 
future research. This may include searching for other antibiotic resistance genes and factors, 
virulence factors and phylogenetic characteristics. This data will enable us to compare our 
isolates to those found locally and globally and give insights into the origin of these clones in our 
setting. 
  
Stellenbosch University  https://scholar.sun.ac.za
88 
 
Addendum A: Materials 
A1 Buffers and media 
Table A1: Buffer compositions 
Media / Buffer Composition 
DNA extraction buffer 5% monosodium glutamate; 50 mM Tris-HCl pH 7.4; 25 mM EDTA 
Proteinase K buffer 5% SDS; 100 mM Tris-HCl pH 7.8; 50 mM EDTA 
TAE 40mM Tris base; 20mM acetic acid; 1mM EDTA 
TE 10 mM Tris-Hcl pH 8.0; 1 mM EDTA 
 
A1.1 Tryptic Soy Broth (TSB) preparation 
15 g Agar powder and 15 g TSB medium were added to a glass container and filled up to 1 L 
with millipore distilled water. The mixture was placed on a stirring heating block until dissolved 
and was then autoclaved for 15 minutes at 121°C to sterilize the media. Once cool to touch, the 
media was cast in sterile plates, allowed to set and stored at 4°C. 
A2 Gel electrophoresis 
A2.1 Agarose gels 
2%: 2 g of SeaKem LE Agarose powder (Lonza) was dissolved in 100 mL 1X Tris-acetate-
EDTA (TAE) at high heat. The composition of the TAE buffer is shown in Table A1. Gels were 
cast and allowed to set for at least 30 minutes prior to use. 
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A2.2 DNA ladders (size markers) 
The KAPA Universal DNA Ladder (KAPA Biosystems) was used for band size comparison in 
the Milheirico (2007) and Kondo (2007) protocols. 
 
Figure A1: KAPA Universal DNA Ladder 
A2.3 Loading dye 
NovelJuice (GeneDireX) was used as a loading dye and is a non-toxic, non-mutagenic 
fluorescent alternative to ethidium bromide staining. It contains three tracking dyes (Xylene 
Cyanol FF, Bromophenol Blue, and Orange G) for visually tracking DNA migration during the 
electrophoresis process. 
 
Figure A2: NovelJuice Tracking Dyes 
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Addendum B: Supplementary Methods 





Dilution of equal volumes of sequencing libraries in hybridization, followed by heat 
denaturation  
Library Normalization 
Normalizes the quantity of each library for equal representation in pooled sample 
PCR Clean-up 
Purification of library DNA and filtering of products to remove short products 
PCR Amplification 
Amplification of tagmented DNA and addition of indices (i5 and i7) required for cluster 
formation 
Tagmentation of Genomic DNA 
Simultaneous fragmentation of DNA and addition of PCR adapters to the ends  
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B2 Genome assembly and annotation commands 
The specific parameters used during the genome assembly and annotation process are listed 
below in grey blocks, preceded by a command description marked with the # symbol. 
# Genome alignment (makeblastdb): A BLAST comparison database 
was generated using the reference sequence with the tool 
makeblastdb 
 
The database type needs to be specified as being DNA (not 
protein) by entering the parameter: –dbtype nucl 
 
# Genome alignment (blastn): A BLAST search was done using the 
blastn tool, to compare the query sequence with the reference 
sequence. 
 
The type of BLAST search needs to be specified as nucleotide to 
nucleotide:  
-task blastn 
The comparison is best viewed in alignment output type 6: 
-outfmt 6 
 
# Genome annotation (RATT): Annotation was transferred between 
two assemblies (one reference, one query) 
 
The type of annotation transfer needs to be specified as 
Assembly 
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